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ABSTRACT 
 Microsporidiosis is an emerging disease among immunocompromised individuals 
who often present with chronic diarrhea.  The intracellular, eukaryotic parasites 
responsible for this pathology can often disseminate, causing multiorgan infections.  
Dissemination of these pathogens is believed to occur through vehicular spread by 
macrophages. The macrophage response to microsporidia is poorly understood.  The 
information, described herein, is focused on defining the host-pathogen interaction and 
subsequent inflammatory response in human monocyte-derived-macrophages (MDM) 
against Encephalitozoon spp. of microsporidia.  Initial studies were designed to better 
define the infection kinetics in MDM using various microscopic analysis and novel 
staining approaches.  Spore adherence and uptake occurs within the first 6 hr and 
parsitophorous vacuole formation within 24 hr after infection.  Replication was shown to 
peak at 72 hr as measured by bromodeoxyuridine incorporation and spore formation by 
120 hr.  Treating the MDM with interferon gamma and bacterial lipopolysaccharide 
reduced parasitic burden.  The role of MDM in initiating monocyte recruitment after 
infection was evaluated using co-culture chemotaxis assays, limited gene and protein 
arrays, ELISA, and neutralizing antibody assays.  These studies identified three major 
monocyte chemoattractants, CCL2, CCL3, and CCL4 that were upregulated, produced, 
and secreted in response to Encephalitozoon infections.  Furthermore, these were 
necessary for monocytic infiltration.  Finally, investigations into the receptors involved in 
initiating host recognition and regulating chemokine production were examined. Toll-like 
receptor (TLR) 2 was shown to be activated by Encephalitozoon spores.  Using siRNA 
gene knock-downs in MDM, TLR2 was revealed to activate NF-κB within 1 hr after 
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parasite exposure resulting in the production of not only CCL3 and CCL4 but also two 
pro-inflammatory cytokines, TNF-α and IL-8.  These results indicate that microsporidia 
are recognized by TLR2 and induce the production of chemotactic and inflammatory 
mediators needed for the recruitment of monocytes/macrophages, which allow for 
parasitic proliferation. 
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CHAPTER 1 
LITERATURE REVIEW 
Introduction 
Microsporidia are a unique group of obligate intracellular eukaryotic parasites 
found virtual everywhere in nature and are known to infect a wide variety of unicellular 
organisms, multicellular invertebrates, and all classes of vertebrates.  There are more 
than 1200 species and 140 genera of microsporidia and the group is characterized by 
their diverse structural, physiological, and genetic characteristics that transcend borders 
of traditional taxonomical classification, making it difficult to place them in any one 
category.  However, two defining characteristics of microsporidia unite all species of 
these organisms together: 1) they all exist as spores in the extracellular environment, 
and 2) they all contain a structurally similar polar filament (tube) which is everted during 
the invasion of a host cell (Bigliardi and Sacchi, 2001; Didier, 2005; Didier et al., 2004; 
Franzen and Muller, 1999; Weiss, 2001; Wittner, 1999). 
The detrimental effects of microsporidiosis have been reported in several 
industries of economic importance, including fisheries, honeybee, and silkworm, and are 
a known cause of infection in laboratory animals (Wittner, 1999).  However, human 
infections have gained greatest recognition since the advent of HIV/AIDS in the early 
1980’s and with the improvement of diagnostic techniques (Bryan and Schwartz, 1999; 
Didier, 2005).  While the disease has primarily been associated with 
immunocompromised individuals, such as HIV/AIDS patients, organ recipients and 
cancer patients, the parasite is becoming reported more frequently as the cause of 
enteric and ocular infections in healthy people (Didier, 2005; Nkinin et al., 2007). 
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Currently, there are 14 species of microsporidia that have been described in 
human infections (Table 1.1), of which, the most prevalent cases described are enteric 
infections from Enterocytozoon bieneusi, Encephalitozoon intestinalis, and 
Encephalitozoon cuniculi (Didier et al., 2004).  Infections primarily occur through the 
ingestion of spores and infect enterocytes of the small intestine, however, infections of 
lung epithelial tissues have also been reported and believed to occur through the 
inhalation of aerosolized spores (Didier, 2005).  E. bieneusi is known to cause infections 
in the small intestine and hepatobiliary tree, but is mostly limited to these sites.  
Similarly, E. cuniculi and E. intestinalis  are also known to infect the small intestine and 
have been identified in disseminated disease affecting the kidneys, liver, spleen, brain, 
and sinus mucosae (Kolter and Orenstein, 1999). 
 
Table 1.1  Microsporidia species that infect humans. 
Microsporidia species 1st Identified 
Brachiola algerae Visvesvara et al. (1999) 
Brachiola connoria Matsubayashi et al. (1959) 
Brachiola vesicularum Cali et al. (1998) 
Encephalitozoon cuniculi Bergquist et al. (1984) 
Encephalitozoon hellemb Friedberg et al. (1990) 
Encephalitozoon intestinalis Cali et al. (1993) 
Enterocytozoon bieneusi Desportes et al. (1985) 
Microsporidium africanum Pinnolis et al. (1981) 
Microsporidium ceylonensis Ashton & Wirasinh (1973) 
Nosema ocularum Bryan et al. (1991) 
Pleistophora ronneafiei Ledford et al. (1985) 
Trachipleistophora anthropopthera Yachnis et al. (1996) 
Trachipleistophora hominis Field et al. (1996) 
Vittaforma corneae Davis et al. (1990) 
a Species was described as E. cuniculi, later determined by Weiser 
(1993) to be N. connori. 
b First cases were believed to be E. cuniculi. 
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Historical Perspective 
During the mid-1800’s, Louis Pasteur was enlisted to help identify preventative 
techniques needed to stop the spread of pebrine disease, which was threatening to 
destroy much of the silk industry in France and Italy.  Infected silkworms were described 
by their tegument being covered, or “peppered” with blackish marks and tissues 
containing oval inclusions.  Pasteur recognized the importance of removing infected 
silkworms and mulberry leaves from silk cultivation farms to prevent further spread of 
the disease.  The agent of pebrine disease was identified by Nägeli in 1857 as the first 
microsporidian and assigned the name Nosema bombycis.  Since this initial discovery 
and classification, microsporidia have been identified in the infections of many insects, 
fishes, and mammals and a cause of negative economic impact in associated industries 
(Didier et al., 2004; Wittner, 1999).    In 1922, Wright and Craighead reported the first 
mammalian microsporidian infection in rabbits by Encephalitozoon cuniculi; affecting 
neurological systems and causing motor paralysis (Wright and Craighead, 1922). 
The first documented case of human microsporidiosis was described by 
Matsubayashi et al. (1959) in a 9-year old boy as Encephalitozoon cuniculi and was 
later determined to be Brachiola connori (Didier, 2005)  In 1973, disseminated 
microsporidiosis was diagnosed in an infant with thymic aplasia (Margileth et al., 1973) 
and a case of ocular infection was detected in an 11-year-old boy (Ashton and 
Wirasinha, 1973).  Human cases of microsporidiosis remained infrequent until the mid 
1980’s.  In 1985, Enterocytozoon bieneusi was established as the etiological agent of 
diarrheal disease in an AIDS patient (Desportes et al., 1985), and, thereafter, cases of 
microsporidiosis became more frequently detected in immunocompromised individuals.  
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Currently, cases of microsporidiosis have been described in immunocompromised 
individuals, including HIV/AIDS patients, organ recipients prescribed 
immunosuppressants, and cancer patients undergoing chemotherapeutic treatments.  
Additionally, microsporidians have been identified in immunocompetent individuals, 
including the very young, elderly, travelers, and contact lens wearers (Didier et al., 
2004). 
Taxonomy of Microsporidia 
Microsporidia have had a long history of being classified and reorganized into 
various groupings based on classical morphological studies and more recent 
phylogentic analyses.  In 1857, Nägeli placed the newly named Nosema bombycis in 
with the group Schizomycetes, which at that time consisted of mostly yeast and 
bacteria.  To make a clearer distinction between the Nosema sp. and other organisms in 
this group, in 1882 the order Microsporida was created (Didier et al., 2004; Franzen and 
Muller, 1999; Wittner, 1999).  During the 1900’s, several classification systems were 
devised based on ultrastructural studies, number of nuclei in each organism, spore 
morphology, and differences in developmental stages; however until recently, the most 
widely accepted classification proposed by Sprague in 1976 was based on membrane 
delimited or direct cytoplasmic development of the parasites.  This system was again 
modified to incorporate the nuclear state as the primary defining characteristic, such as 
diplokaryon or haplokaryon, in organizing specific species of microsporidia (Franzen 
and Muller, 1999). 
While microsporidia have been classified as eukaryotic protozoa, new 
phylogenetic studies suggest these organisms are more closely related to fungi, and 
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therefore should be reclassified as such (Gill and Fast, 2006; Thomarat et al., 2004).    
Initial phylogenetic studies of ribosomal RNA and elongation factors would argue that 
these organisms were primitive eukaryotes that diverged early in history, prior to gaining 
the endosymbiont α-proteobacteria and should be placed with Archezoa (Cavalier-
Smith, 1991; Gill and Fast, 2006).  However, later studies that focused on the genes of 
α- and β-tubulin, mitochondrial heat-shock protein 70, TATA-box binding protein, the 
large subunit of RNA polymerase II, and subunits of pyruvate dehydrogenase proposed 
a stronger relationship between microsporidia and fungi (Gill and Fast, 2006).  
Additionally, structural and physiological similarities between fungi and microsporidia 
have been noted, such as the abilities to form spores and synthesize chitin, a 
component of the spore coat (Thomarat et al., 2004).  The structural, biological, and 
recent phylogenetic similarities between microsporidia and fungi have strengthened the 
idea that these organisms are related to fungi; however, the exact placement within this 
kingdom has not been resolved.  Current studies have placed them with the 
zygomycetes (Keeling, 2003) and chytrids (James et al., 2006), while another report 
suggests that they are a sister to a combined basdiomycetes/ascomycetes group (Gill 
and Fast, 2006).  At this time, additional studies must be completed to identify the 
complete taxonomic placement of these eukaryotes. 
Biology of Microsporidia 
 Structure.  Microsporidia have a unique ultrastructural morphology and 
molecular biology that easily distinguishes them from other enteric organisms; however, 
they are small enough that technical and expensive diagnostic techniques, such as 
electron microscopy, are needed to determine their presence from other pathogens 
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(Didier, 2005).  The infectious stage for all microsporidia is an oval-shaped, 
environmentally resistant spore, typically measuring from 1 to 12 µm in length (Cali and 
Takvorian, 1999); however, those that infect humans range in size from 1 to 3 µm 
(Didier, 2005).  The spore coat is comprised of two layers: an electron-dense, 
proteinaceous exospore and an electron lucent endospore composed of chitin (Bigliardi 
and Sacchi, 2001; Didier, 2005; Franzen and Muller, 1999; Vavra and Larsson, 1999).  
Closer observations of the spore layers of Encephalitozoon reveal that the exospore 
consists of three layers of varying densities and the endospore is a space with bridges 
of chitin that connect the exospore to the plasma membrane of the sporoplasm (Bigliardi 
and Sacchi, 2001; Vavra and Larsson, 1999).  The spore coat functions to protect the 
integrity and viability of the sporoplasm from environmental pressures including acidic or 
alkaline conditions that range from pH 4-9, freezing temperatures, dehydration, and 
changes in tonicity (Didier, 2005).  However, inactivation of spore viability can occur by 
various chemicals, including extreme acidic and alkaline solutions, 70% ethanol, sodium 
hypochlorite (Santillana-Hayat et al., 2002), and UV radiation (Marshall et al., 2003). 
A classical plasma membrane delimits the sporoplasm from the spore coat.  The 
intracellular contents of the sporoplasm include several organelles needed for 
eukaryotic survival, which include a membrane-defined nucleus, observed in a 
monokaryon or dikaryon configuration depending upon the species of microsporidia, a 
modified endoplasmic reticulum usually adorned with ribosomes, free cytoplasmic 
ribosomes, and  modified golgi bodies (Vavra and Larsson, 1999).  Some cytoplasmic 
characteristics separate this group of organisms from other eukaryotes, such as atypical 
ribosomes and golgi bodies.  The ribosomes are prokaryote-like having a 70S 
  7
sedimentation rate and lack the 5.8S rRNA.  The golgi bodies are not composed of 
stacked lamellar cisternae, but are a membrane bound aggregation of vesicles.  In 
addition, these organisms have been shown to lack mitochondria (Franzen and Muller, 
1999; Vavra and Larsson, 1999), however, a mitochondria-like organelle, called the 
mitosome, has recently been identified (Williams et al., 2002).  Newer evidence shows 
that some elements of the classical mitochondria are preserved in the mitosome, yet its 
function is largely not understood (Burri et al., 2006; Goldberg et al., 2008). 
Unlike most eukaryotic organisms, microsporidia also contain unique elements 
used during the infection process, which include the posterior vacuole, polaroplast 
membranes, a polar sac-anchoring disk, and a polar filament (tube) (Fig. 1.1A).  The 
polar filament is found in the resting spore coiled around the cytoplasmic contents within 
the plasma membrane.  The number of coils in the spore is used to differentiate 
between species of microsporidia.  Upon induction of polar filament extrusion, the tube 
turns inside out as it fires out of the apical region of the spore (Fig 1.1B) (Bigliardi and 
Sacchi, 2001; Didier et al., 2004; Franzen, 2004; Vavra and Larsson, 1999).  The base 
of the polar tube is hinged to the polar sac-anchoring disk, a bell-shaped complex 
located at the spore’s apex, which functions to maintain the attachment of the polar tube 
to the spore after eversion.  The polaroplast is a membrane system of lamellae that 
unite continuously with the polar sac and outer membrane of the polar filament (Bigliardi 
and Sacchi, 2001).  It is proposed that the polaroplast is pushed through the polar tube 
and forms the new plasma membrane of the meront at the tip of the filament.  The 
posterior vacuole is believed to be the force behind the extrusion and ejection of spore 
contents, because this vacuole swells when the spore has been activated (Bigliardi and 
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Sacchi, 2001; Franzen, 2004).  A universal trigger for activation of the spore has not 
been identified, but several conditions are known to induce activation for individual 
species of microsporidia, such as spore exposure to acidic and alkaline conditions, 
temperature changes, cations, ultraviolet light, and biological complexes, such as mucin 
(Keohane and Weiss, 1999). 
 
Figure 1.1  Major structures of the microsporidian spore.  (A) A diagram of a 
microsporidian spore showing the spore coat layers, nucleus, and major organelles 
utilized during infection∗.  (B) A DIC light microscopy image of an E. cuniculi spore (s) 
after the polar filament (arrows) has fired and has forced out the sporoplasm (sp). 
 
Life Cycle.  The life cycle of microsporidia begins after activation of the spore 
and eversion of the polar tube results in successful penetration of a host cell and the 
intracellular entry of the sporoplasm.  The newly acquired sporoplasm proceeds to 
replicate by merogony, increasing numbers of meronts and sporonts, and differentiates 
                                                            
∗ Image reprinted from Annual Review of Microbiology, Vol. 56, P. Keeling and N. Fast, Microsporidia: 
Biology and Evolution of Highly Reduced Intracellular Parasites, Pages 93-116, Copyright 2002, with 
permission from Annual Reviews. 
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into sporoblasts and mature spores by sporogony (Fig 1.2).  Upon spore maturation, the 
host cell is lysed and the newly formed spores are released into the extracellular 
environment, where they are able to infect additional nearby host cells or are excreted 
into the extracorpeal environment.  (Bigliardi and Sacchi, 2001; Franzen, 2004; Vavra 
and Larsson, 1999). 
 
Figure 1.2  Microsporidia life cycle. Infection begins by extrusion of the polar tube 
from the spore, penetrating the host membrane, and expulsion of the sporoplasm into 
the host cytoplasm (A).  Merogony proceeds in a membrane bound parasitophorous 
vacuole (Encephalitozoon spp.) with meront reproduction by binary fission in direct 
contact with the membrane and the development of sporonts (B).  During sporogony, 
newly formed sporonts develop into sporoblasts (C), and finally mature spores, which 
are released by lysis of the host cell (D). 
 
The exact process of division and development depends upon the species of 
microsporidia.  Enterocytozoon bieneusi, the most prevalent cause of intestinal 
infections in humans, begins development within the host cell in direct contact with the 
cytoplasm.  The uninucleate meront divides to produce a multinucleate meront which 
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then undergoes sporogony to generate a multinucleate sporont.  The final development 
of independent spores is completed during cytokinesis.  In contrast, Encephalitozoon 
cuniculi and Encephalitozoon intestinalis, causes of intestinal infection and 
disseminated diseases in humans, begin development in the host cell inside a 
membrane bound vacuole, called the parasitophorous vacuole (PV), and avoids contact 
with the host cytoplasm.  Meronts develop in contact with the inside membrane of the 
parasitophorous vacuole and replicate by binary division.  Sporonts detach from the 
membrane and undergo development in the center of the vacuole to produce mature 
spores.  Both methods of spore development result in host cell lysis and the release of 
spores into the environment (Bigliardi and Sacchi, 2001; Didier, 1998). 
Although polar filament extrusion is thought to be the predominant method of 
parasitic invasion, actin-dependent phagocytosis has also been suggested and shown 
to occur in macrophages and lung fibroblast cells (Couzinet et al., 2000; Franzen et al., 
2005b).  The internalization and the intracellular fate of the spores has been a constant 
topic of discussion.  TEM studies of E. cuniculi infected murine macrophages showed 
that ferritin and acid phosphatase labeled lysosomes do not fuse with the 
parasitophorous vacuoles of developing parasites (Weidner, 1975).  Supporting 
evidence from Fausshauer et al. (2005) showed that pre-labeled endocytic vesicles did 
not fuse with the PV, nor was the late endocytic lysosomal marker LAMP-1 found in the 
PV membrane.  In contrast, other studies have suggested that phagosomes fuse 
immediately with lysosomes, as demonstrated by the vacuoles capability to acquire 
markers of phagolysosomes, including LAMP-1, LAMP-2, CD68, and cathepsin D 
(Couzinet et al., 2000; Franzen et al., 2005b) and from observations of rhodamine-
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dextran labeled lysosomal compartments ability to fuse with spore vacuoles (Couzinet 
et al., 2000).  Taken together, these studies suggest that internalized spores must 
escape the lysosome to proliferate within the cell and support  Franzen et al. (2005b) 
findings that some internalized spores fire the polar tube out of the phagolysosomes, 
allowing for the potential escape of the sporoplasm. 
Epidemiology 
Human cases of microsporidiosis have been reported world-wide and it is only 
recent that the prevalence of this disease has been better understood with increased 
diagnostic technologies.  However, this data still varies greatly due to differences in 
diagnostic methods and a lack of random sampling (Bryan and Schwartz, 1999).  Early 
prevalence rates among AIDS patients with diarrhea were reported to range between 
5% and 50% with an overall suggested prevalence of 15%, whereas,  rates amongst 
healthy individuals with diarrhea were seemingly lower and reported to range between 
1.3% and 22% (Didier, 2005).  Additional reports in Niger and Vietnam showed a 
prevalence of 10.5% and 9.5%, respectively, amongst HIV-infected individuals (Espern 
et al., 2007) and 76.9% in HIV-infected children (Tumwine et al., 2005), whereas, a 
study of three United States cities reported only a prevalence of 1.5% amongst HIV 
patients (Dworkin et al., 2007).  These contrasts reflect possible differences in water 
sanitation and food handling practices and the availability of effective 
chemotherapeutics amongst countries.  Most reports have focused on sampling from 
symptomatic individuals; however, a study of microsporidiosis in Cameroon of sub-
Sharan Africa surprisingly revealed the prevalence in healthy people without diarrhea 
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was higher (67.5%) than in immunocompromised individuals (24%-35.7%) (Nkinin et al., 
2007). 
Age related incidences have also been reported for healthy individuals exhibiting 
symptoms and shown to have higher prevalence rates amongst young children and the 
elderly.  Studies of HIV negative children have reported ranges between 4.1% to 6.6% 
(Leelayoova et al., 2005; Tumwine et al., 2005) with the highest reports amongst 
children between 12-23 months-old (Leelayoova et al., 2005).  In HIV negative elderly 
patients with an average age of 75 years, the prevalence was 17.05% (Lores et al., 
2002).  These occurrences support the hypothesis that susceptibility to infection may be 
also associated with special age-related characteristics of the immune system (Lores et 
al., 2002). 
Transmission 
Various modes of transmission to humans have been suggested based on 
environmental detection of microsporidia and the prevalence of the disease.  The 
parasite is known as a natural cause of infection in domestic and feral animals and has 
raised concern about its zoonotic potential to cause cases of human microsporidiosis 
(Didier, 2005; Wasson and Peper, 2000).  Direct evidence of zoonotic transimission 
from domestic animals to children has been reported (Cama et al., 2007; McInnes and 
Stewart, 1991) and further studies suggest that birds participate in the airborne and 
water transmission of spores (Graczyk et al., 2007).  The potential for transmission by 
contaminated food and water sources has been supported by studies detecting human-
virulent strains of microsporidia in slaughterhouse animals, dairy from cows, fresh 
produce, and water sources for consumption (Buckholt et al., 2002; Dowd et al., 2003; 
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Jedrzejewski et al., 2007; Lee, 2008).  In addition, the microsporidia Brachiola algerae, 
once believed to have potential as a mosquito bioinsecticide (Becnel et al., 2005), was 
diagnosed as the cause of fatal myositis in a diabetic patient (Coyle et al., 2004), raising 
concern for the potential vector-borne spread of disease.  
Disease and Treatment 
 The clinical manifestation of microsporidiosis is dependent upon the initial 
infection site, immune status of the host, and the species of microsporidia.  Disease 
typically results from the ingestion of spores resulting in the infection of enterocytes of 
the small intestine, but respiratory infections from inhalation of spores and ocular 
disease have also been confirmed (Didier, 2005).  While milder symptoms of 
gastrointestinal disease have been reported for immunocompetent individuals, more 
severe disease symptoms, such as chronic enteric infections and disseminated disease, 
have been reported for immunocompromised individuals.  Immunocompetent individuals 
with intestinal disease typically develop self-limited cases of diarrhea lasting 2-3 weeks, 
which results in the clearance of pathogen (Didier and Bessinger, 1999).  Healthy 
individuals have been diagnosed with ocular infections that required treatment for 
resolution (Sagoo et al., 2007).  In addition, data suggests that some immunocompetent 
individuals are asymptomatic carriers of persistent infections (Nkinin et al., 2007). 
In contrast to healthy hosts, immunodeficient individuals can develop serious 
cases of intestinal microsporidiosis that result in chronic diarrhea and is associated with 
blunting of intestinal microvilli and decreased nutrient absorption.  The chronic diarrhea 
can lead to wasting and death.  While chronic diarrhea is the most prevalent pathology, 
disseminated disease in immunocompromised individuals infected with Encephalitozoon 
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spp. has been shown to affect the liver, gall bladder, kidneys, heart, and bladder (Kolter 
and Orenstein, 1999). 
 Many treatments have been prescribed for microsporidiosis, but a limited number 
of therapies have been successful (Conteas et al., 2000).  Albendazole, an inhibitor of 
β-tubulin polymerization, has been shown to be effective against intestinal 
Encephalitozoon spp. infections (Blanshard et al., 1992), but is only variably effective 
against E. bieneusi (Dieterich et al., 1994).  Fumagillin, an antibiotic produced by 
Aspergillus fumigatus, has been effective in treating Encephalitozoon ocular infections 
(Rosberger et al., 1993), as well as intestinal E. bieneusi infections (Molina et al., 1997).  
In addition, antiretroviral therapy was shown to increase immune competency among 
HIV patients and indirectly decrease cases of microsporidiosis (Conteas et al., 2000).     
Adaptive Immune Responses to Microsporidia 
 Role of T Cells in Adaptive Immunity.  T cells are critical for host adaptive 
responses to infections.  CD4+ T cells provide cytokines that help to activate either cell-
mediated immunity or humoral responses.  Activation of these two adaptive responses 
is dependent upon CD4+ T cell differentiation into Th1 or Th2 cells.  These two sub-
populations of CD4+ T cells differ in the profiles of cytokines that will be released, which 
ultimately determines the function of the adaptive response (Janeway et al., 2005). 
 Cell-mediated immunity is promoted by the differentiation of CD4+ T cells into 
Th1 cells and the release of Th1 type cytokines, including interferon-gamma (IFN-γ).  
The effects of these Th1 mediators are most notably seen on CD8+ T cells and 
macrophages.  When activated by Th1 responses, CD8+ T cells deliver cytotoxic 
proteins to target cells upon recognition of antigen.  Perforin is one cytolytic protein that 
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is released and forms pores in the membranes of target cells, allowing for intracellular 
contents to leak out.  In addition, granzymes, which induce apoptosis, are released and 
enter the target cell using the perforin pore (Janeway et al., 2005).  Macrophages are 
also activated by Th1 responses and induce an array of intracellular killing mechanisms.  
Some of these mechanisms include phagosome acidification, lysosomal fusion, and 
generation of reactive oxygen and nitrogen species.  Activation of macrophages also 
induces the secretion of IL-12 which directs the differentiation of CD4+ T cells into Th1 
effector cells (Beutler, 2004). 
 The differentiation of CD4+ T cells into Th2 cells and subsequent release of Th2 
cytokines induces humoral immunity, activating the production of antibodies and 
complement proteins.  Th2 cytokines involved in humoral effects include IL-4, IL-5, IL-
10, and IL-13.  Th2 responses enhance B cell activation and differentiation, while 
inhibiting the activation of macrophages.  The effects of humoral immunity involve 
coating pathogens with antibodies and proteins that neutralize their intracellular entry, 
opsonize them to enhance phagocytosis, and activate the complement system 
(Janeway et al., 2005).   
Role of T Cells in Microsporidiosis.  T lymphocytes and cell-mediated immune 
responses against microsporidia have been proven to promote host resistance to 
microsporidiosis.  Early evidence for cell-mediated immunity was gathered from 
experiments on athymic and severe combined immunodeficiency (SCID) mice that 
acquired lethal microsporidia infections after challenge with E. cuniculi.  Resistance to 
infections was achieved by adoptive transfer of sensitized T cells into these 
immunocompromised mice (Schmidt and Shadduck, 1983), whereas the transfer of B 
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lymphocytes did not promote survival (Enriquez, 1997).  As well, supernatants from 
infected lymphocytes were shown to activate macrophages to destroy microsporidia 
(Schmidt and Shadduck, 1984). 
The role of T lymphocytes and the subtypes of T cells have been further defined 
in murine microsporidiosis.  Khan et al. observed that CD8+ T cell knock out mice 
succumb to E. cuniculi infection (Khan et al., 1999), whereas, CD4+ T cell knock out 
mice survive and retain a normal antigen-specific cytotoxic T cell response (Moretto et 
al., 2000).  Although CD4+ T cells do not affect disease outcome in mice (Moretto et al., 
2000), they are believed to serve a role in protection in humans.  Susceptibility to 
microsporidia increases as CD4+ T cell counts decline even in the presence of normal 
CD8+ T cells (Kotler and Orenstein, 1998).  Furthermore, treatment with anti-retroviral 
therapy, which increases CD4+ T cell counts, reduces parasitic load (Hale-Donze and 
Didier, 2007). 
To further delineate the mechanism of killing used by CD8+ T cells, perforin gene 
knock out mice were challenged with E. cuniculi.  Perforin molecules are secreted by 
CD8+ T cells and exhibit their cytolytic effects on target cells by forming holes in the 
plasma membrane.  Lethal infections were observed in perforin knock out mice and a 
greater parasitic burden was found in tissues (Khan et al., 1999). 
Role of Th1 Cytokines in Microsporidiosis.  Th1 cytokine responses have 
been shown to play an important role in host protection to microsporidia infections.  
Increased levels of IFN-γ have been observed in immunocompetent mice challenged 
with E. cuniculi (Khan and Moretto, 1999) and E. intestinalis (El Fakhry et al., 2001).  
The in vitro effects of IFN-γ have been observed in cultures of murine macrophages that 
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decreased parasite burden (Didier and Shadduck, 1994) and in vivo effects in IFN-γ 
receptor knock out mice challenged with E. intestinalis, which resulted in chronic 
infections (Achbarou et al., 1996).  The protective nature of IFN-γ and IL-12 in mice was 
observed by an in vivo antibody neutralization experiment, in which, IFN-γ and IL-12 
neutralized mice succumbed to infection.  IL-12 is known to stimulate IFN-γ production, 
therefore, the neutralization of this cytokine was believed to decrease IFN-γ responses 
leading to fatal infections (Khan and Moretto, 1999).  Susceptibility to infection was 
observed in IFN-γ and IL-12 knock out mice and further supported a requirement for 
IFN-γ in resistance to infection (Khan and Moretto, 1999).  In a recent study, the 
requirement for IFN-γ in microsporidia clearance was assessed by administering IFN-γ 
therapy to SCID mice, which resulted in their prolonged survival (Salat et al., 2008). 
 Role of Humoral Immunity in Microsporidiosis.  The production of antibodies 
against microsporidia infections is well documented in animal models of infection and in 
the human population; however, the protective role of antibodies is not well understood 
(Omura et al., 2007; Sak and Ditrich, 2005).  Neiderkorn et al. first suggested that 
antibodies produced in response to infection may enhance phagocytosis of the parasite 
by macrophages and induce intracellular killing by lysosomal fusion with the 
parasitophorous vacuole (Niederkorn and Shadduck, 1980).  A supporting study 
observed a decrease in infected cells when spores were incubated with anti-
microsporidial exospore monoclonal antibody prior to challenge (Enriquez et al., 1998).  
More recently, a novel anti-exospore antibody was used in vivo to prolong the survival 
of CD4+ reconstituted SCID mice, resulting in decreased parasite burden in post-
mortem peritoneal smears (Sak et al., 2006). 
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In contrast, full resistance did not ensue when B lymphocytes were transferred to 
athymic or SCID mice, as all mice succumbed to infection (Enriquez, 1997).  Passive 
transfer of immune sera also did not promote resistance to infection in athymic mice 
(Schmidt and Shadduck, 1984).  While the antibody response has been documented, it 
is proposed that it does not play a pivotal role in resistance to infection, but may 
enhance the efficiency of the immune response. 
Innate Immune Responses to Microsporidia 
Role of Macrophages in Innate Immune Responses.  Macrophages are found 
throughout the body of the host and are central in defending epithelial barriers from 
entry by microorganisms, as they are the first cells to encounter pathogens.  Although 
these cells are primarily recognized for their immune functions, they also contribute to 
host homeostasis and overall maintenance by scavenging and removing dead cells 
during embryonic development, bone remodeling, and tissue repair.  Macrophages are 
derived from pluripotent haematopoietic stem cells found in bone marrow, which mature 
into blood monocytes.  Monocytes migrate into tissues becoming tissue macrophages 
and make up a diverse population of cells in the body, including alveolar macrophages 
in the lungs, Kupffer cells in the liver, osteoclasts in bone, and microglial cells in 
nervous tissue.  Macrophages primary functions in host defense are to recognize, 
engulf, and destroy pathogens, but they are also considered a link to adaptive immunity 
and function as antigen-presenting cells that can activate T cell responses (Janeway et 
al., 2005). 
Macrophages as Phagocytes.  Macrophages role in host immunity was first 
recognized by Ellie Metchnikoff when he observed cells in a sea star surround and 
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engulf a thorn that was introduced into the invertebrate (Metchnikov, 1884).  The 
interaction between the host and microbe activated host surface receptors and 
intracellular signaling mechanisms which induced cytoskeletal rearrangements, the 
extension of the plasma membrane, and promoted engulfment.  Receptors found on 
phagocytes involved in uptake can either identify microbes opsonized with antibody and 
complement proteins, such as the Fc and complement receptors, or can directly 
recognize surface molecules of the organism (Underhill and Ozinsky, 2002). 
Recognition of Pathogens by Macrophages.  Macrophage sensing is achieved 
through an array of germline encoded receptors found on the surface of the cell and 
inside endosomal compartments known as pattern recognition receptors (PRR).  These 
receptors are triggered by the recognition of pathogen-associated molecular patterns 
(PAMPs) found on bacteria, viruses, protozoans, and fungi.  Activation of these 
receptors results in initiation of innate immune responses.  More recently, intracellular, 
non-compartmentalized molecules have been identified and found to recognize PAMPs 
and stimulate immune responses (Medzhitov, 2007; Takeda and Akira, 2005).  While 
PRR are a large, diverse family of receptors and includes the β-glucan receptor, dectin-
1 and the macrophage mannose receptor, the best characterized PRR are the toll-like 
receptors   (Medzhitov, 2007; Underhill and Ozinsky, 2002). 
Toll-like Receptors.  The discovery of Toll and its function in innate immune 
responses was first identified in Drosophila, but soon lead to the identification of Toll 
homologues in mammals (Takeda and Akira, 2005).  There have been 11 members of 
TLR identified in mammals, of which, 10 TLR are found in humans.  Characteristically, 
these type I transmembrane receptors contain an extracellular leucine rich repeat (LRR) 
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domain used to recognize conserved molecular products and an intracellular Toll/IL-1  
receptor (TIR) domain to recruit adaptor proteins that initiate signaling cascades.  
Although TLR are believed to form homodimers, some TLR are reported to 
heterodimerize with each other, such as TLR2 with TLR1, and TLR2 with TLR6.  In 
addition, TLR4 is known to collaborate with molecules CD14 and MD2 in the recognition 
of lipopolysaccharide.  TLR have been shown to recognize a variety of organisms, 
however, individual TLR are specific for molecular components (Table 1.2).  These 
include triacyl lipopeptides by TLR1; peptidoglycan, zymosan, and lipoarabinomannan 
by TLR2; double-stranded RNA by TLR3; lipopolysaccharide by TLR4; flagellin by 
TLR5; diacyl lipopeptides and zymosan by TLR6; single-stranded RNA by TLR7 and 
TLR8; and CpG DNA by TLR9 (Medzhitov, 2001; Takeda and Akira, 2005). 
 
Table 1.2  Toll-like receptors and ligands (Akira and Takeda, 2004) 
Receptor Ligand 
TLR1 Triacyl lipopeptides 
TLR2 Peptidoglycan 
 Lipoteichoic acid 
 Lipoarabinomannan 
 Glycoinositolphospholipids 
 Zymosan 
TLR3 Double-stranded RNA 
TLR4 Lipopolysaccharide 
TLR5 Flagellin 
TLR6 Diacyl lipopeptides 
 Zymosan 
TLR7 Single-stranded RNA 
TLR8 Single-stranded RNA 
TLR9 CpG-containing DNA 
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While triggering TLR results in divergent gene products, the initial adapter 
proteins in these different cascades are often shared (Fig. 1.3).  The MyD88 pathway  
 
 
Figure 1.3  TLR signaling pathways.  TLR triggering stimulates the recruitment of the 
adapter molecule MyD88 to the TIR domain of the receptor.  Association of IRAK1, 
IRAK4, and TRAF6 induces the phosphorylation of IκB and results in activation of NF-
κB.  Additionally, TLR signaling has been shown to activate MAPK signaling and TRIF-
dependent IRF3 pathways. 
 
was first shown to be important in establishing an inflammatory response that included 
the production of TNF-α and IL-12 cytokines (Takeda and Akira, 2005).  The recruitment 
of the adapter protein MyD88 to the TIR domain of the activated TLR leads to 
recruitment of IRAK-4 and the phosphorylation of IRAK-1.  IRAK-1’s association with 
TRAF6 leads to the diversion of two distinct signaling pathways.  One path induces 
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mitogen-activated protein kinase (MAPK) signaling, while the other path ultimately leads 
to the phosphorylation of inhibitor of nuclear factor kappa B (IκB).  ΙκB functions to bind 
cytosolic nuclear factor kappa B (NF-κB) and prevent its translocation into the nucleus.  
Phosphorylation of ΙκB leads to the ubiquitination and degradation of this molecule, and 
ultimately results in the release and nuclear translocation of NF-κB (Medzhitov, 2001; 
Takeda and Akira, 2005).  NF-κB activation has been described in mediating the 
transcription of a number of inflammatory cytokines, chemokines, and co-stimulatory 
molecules (Medzhitov, 2001).  Additionally, TLR4 and TLR3 have been shown to signal 
independently of MyD88 by recruiting the adapter molecule TRIF.  TRIF signaling 
activates the transcription factor interferon regulatory factor 3 (IRF-3) leading to the 
production of type I interferons (IFN-α and IFN-β) and late phase activation of NF-κB 
(Medzhitov, 2001; Takeda and Akira, 2005). 
Intracellular Killing of Pathogens.  Once the pathogen has been recognized, 
many of the receptors activate phagocytosis (Underhill and Ozinsky, 2002).  The newly 
developed phagosome that surrounds the internalized microbe quickly becomes 
extremely toxic and begins destroy and degrade the organism.  This process serves two 
purposes in immunity: killing of the organism preventing further progression of potential 
disease, and processing antigens allowing for co-presentation with MHC II class 
molecules on the cell surface leading to the activation of CD4+ T cell responses.  The 
microbe-containing phagosome quickly becomes acidic and binds to lysosomes 
containing degradative enzymes and antimicrobial peptides, which are released into the 
phagolysosome (Beutler, 2004; Janeway et al., 2005).  Classical activation of 
macrophages induces additional killing mechanisms within the cell.  Activation of 
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macrophages can occur through direct interaction between the microbe and host cell 
surface molecules, such as reported interactions between bacteria and host toll-like 
receptors, or by host secreted stimulatory molecules, such as the cytokine IFN-γ.  These 
additional mechanisms include the generation of toxic superoxide and hydrogen 
peroxide molecules by phagosome bound NADPH oxidase and the production of 
reactive nitrogen molecules by nitric oxide synthase (Beutler, 2004; Janeway et al., 
2005; Underhill and Ozinsky, 2002). 
 Induction of Inflammatory Cytokines.  Macrophage-microbe interactions lead 
to the release of cytokines into surrounding tissues, which contribute to the overall 
activation of acute phase responses and effector cells which limit microbial spread 
(Janeway et al., 2005).  TNF-α and IL-1 are two common cytokines produced in 
response to infection.  These mediators have been documented to induce the 
production of vascular occluding proteins, the release of opsonizing acute phase 
proteins, and an increase body temperature (Beutler, 2004; Janeway et al., 2005).  
Additionally, these two cytokines initiate the expression of adhesion molecules, such as 
E-selectin and VCAM-1, in vascular tissues, which contribute to cellular recruitment 
(Janeway et al., 2005). 
The chemotactic cytokines, or chemokines, are a family of signaling proteins 
secreted to induce the recruitment of immune effector cells to sites of injury or infection.  
Chemokines bind to seven-transmembrane, trimeric G-protein coupled receptors on 
target cells.  Activation of the chemokine receptor induces cell migration by intracellular 
actin reformation of the lamellipodia and increases in surface integrins that function in 
adherence (Baggiolini, 1998).  CCL2 (monocyte chemoattractant protein 1, MCP-1), 
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CCL3 (macrophage inflammatory protein 1α, MIP-1α), CCL4 (macrophage inflammatory 
protein 1β, MIP-1β), and CXCL8 (interleukin-8, IL-8) are known chemokines produced 
by macrophages in response to microbes in an effort to recruit immune effector cells 
(Laing and Secombes, 2004).  The gene expression of these four chemokines can be 
regulated by the transcription factor NF-κB (Grove and Plumb, 1993; Kunsch and 
Rosen, 1993; Teferedegne et al., 2006; Widmer et al., 1993).  Chemokines are 
promiscuous molecules; typically able to bind to more than one type of chemokine 
receptor and recruit a diverse profile of immune cells.  CCL2, CCL3, and CCL4 
predominately induce migration of monocytes, whereas IL-8 is classically known as a 
recruitment factor for neutrophils (Laing and Secombes, 2004). 
Intracellular Killing of Microsporidia.  Nitric oxide responses have proven to 
be important mediators of intracellular killing and disease resistance for a number of 
microbial pathogens (James, 1995).  The role of nitric oxide in host resistance to 
microsporidia has been studied by a limited number of groups and their interpretation of 
results provide conflicting views on the importance of this response to infection.  
Franzen et al. (2005a), reported that the levels of nitrate and nitrite, which correlates to 
nitric oxide production, did not increase in naïve primary human macrophage cultures 
challenged with Encephalitozoon spp.  Didier et al. (1994), showed that cultures of 
murine macrophages activated with LPS, IFN-γ, LPS + IFN-γ, or TNF-α prior to infection 
with spores of E. cuniculi resulted in decreased number of spores after 48 hr in 
comparison to untreated cultures.  In further studies, cultures activated with IFN-γ or the 
combination of LPS and IFN-γ resulted in the detection of increased levels of nitrite and 
microbiostatic activity, whereas the addition of the nitric oxide synthase inhibitor N3 
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monomethyl-L-arginine (NMMA) decreased the production of nitric oxide and prevented 
microbial killing (Didier, 1995).  Classical activation of resting macrophages by bacterial 
lipoproteins or cytokines is important in the initiation of nitric oxide responses (James, 
1995).  While these studies support a role for classical activation of macrophages in 
nitric oxide killing of microsporidia, Khan et al. (1999), showed that mice deficient in 
inducible nitric oxide synthase, the enzyme responsible for nitric oxide production, were 
able to survive a high dose of microsporidia challenge suggesting that this molecule 
does not participate in resistance to infection. 
In addition to nitric oxide responses, Didier et al. (2001), investigated the role of 
reactive oxygen intermediates in resistance to infection.  They observed that mice with 
defective phagocytic oxidative respiratory burst challenged with spores of E. cuniculi 
were susceptible to longer infections and a higher parasitic burden.  Five weeks after 
challenge, infection was still observed in oxidative burst deficient mice, whereas, 
infection was not observed in wild type mice.  However, deficient mice did not succumb 
to infection.  This suggests that oxidative respiratory bursts may contribute to resistance 
and a more efficient resolution of infection, but is ultimately not responsible for microbial 
clearance. 
Cytokine Response to Microsporidia.  Studies investigating the cytokine 
responses to microsporidia infections have provided limited insight.  Franzen et al. 
(2005a), reported elevated levels of TNF-α, IFN-γ, and IL-10 cytokines from human 
macrophages in response to human virulent species of microsporidia.  In support of its 
protective function, TNF-α was shown to inhibit E. cuniculi replication when added to 
murine cultures of macrophages (Didier and Shadduck, 1994).  In addition, elevated 
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levels of TNF-a have been detected in fecal samples of AIDS patients with 
microsporidiosis and is believed to contribute to the disease pathology (Sharpstone et 
al., 1997). 
Statement of Research Problem and Hypothesis 
The immunobiology of microsporidiosis is not well understood and there is limited 
information about the role of macrophages in this disease.  From the analyses of 
pathology reports, macrophages have been suggested as the facilitator of dissemination 
of the parasite from initial infection sites (Orenstein, 2003; Soule et al., 1997).  
Internalization of microsporidia has been observed in macrophages, however, there is 
some debate whether the parasite is able to replicate within the cell and produce mature 
spores or is degraded by the cell (Didier and Shadduck, 1994; Franzen et al., 2005b; 
Weidner, 1975).  The focus of chapter 2 is the delineation of parasite proliferation within 
primary human macrophages and the effects of IFN-γ priming of macrophages on 
parasite development.  A second aspect of the work centered on the production of 
chemokines due to the host-parasite interaction and the recruitment of monocytes.  
Parasite dissemination is believed to occur via macrophages (Orenstein, 2003), 
therefore, the functional chemokine gradient produced in response to infection was 
determined and a co-culture chemotaxis assay system was utilized to establish key 
chemokines needed for monocyte recruitment.  The functional role of chemokines and 
the recruitment of additional monocytes to sites of infection are the focus of chapter 3.  
Encephalitozoon interactions with primary human macrophages have been shown to 
mediate the production of several cytokines (Franzen et al., 2005a).  However, a 
receptor required to initiate parasite recognition and subsequent production of these 
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mediators has not been described.  The focus of chapter 4 is the elucidation of the role 
of toll-like receptor recognition, intracellular signaling activation, and cytokine and 
chemokine production via this mechanism. 
Statement of Research Objectives 
The goal of this research was to gain a greater understanding of the host-
pathogen relationship and the innate immune responses produced during this 
interaction between species of the Encephalitozoon and primary human macrophages.  
The specific objectives of this research were 1) to establish if Encephalitozoon spp. can 
cause an active infection in primary human macrophages that leads to parasite 
proliferation and the production of mature spores, 2) to determine if infection induces 
the production of a functional chemokine gradient that leads to the recruitment of 
additional monocytes to sites of infection, and 3) to elucidate the role of toll-like 
receptors in the recognition of Encephalitozoon spp. which leads to the production of 
pro-inflammatory responses. 
References 
Achbarou A., Ombrouck C., Gneragbe T., Charlotte F., Renia L., Desportes-Livage I. 
and Mazier D. (1996) Experimental model for human intestinal microsporidiosis 
in interferon gamma receptor knockout mice infected by Encephalitozoon 
intestinalis. Parasite Immunol 18, 387-92. 
Akira S. and Takeda K. (2004) Toll-like receptor signalling. Nat Rev Immunol 4, 499-
511. 
Ashton N. and Wirasinha P. A. (1973) Encephalitozoonosis (nosematosis) of the 
cornea. Br J Ophthalmol 57, 669-74. 
Baggiolini M. (1998) Chemokines and leukocyte traffic. Nature 392, 565-8. 
Becnel J. J., White S. E. and Shapiro A. M. (2005) Review of microsporidia-mosquito 
relationships: from the simple to the complex. Folia Parasitol (Praha) 52, 41-50. 
  28
Bergquist N. R., Stintzing G., Smedman L., Waller T. and Andersson T. (1984) 
Diagnosis of encephalitozoonosis in man by serological tests. Br Med J (Clin Res 
Ed) 288, 902. 
Beutler B. (2004) Innate immunity: an overview. Mol Immunol 40, 845-59. 
Bigliardi E. and Sacchi L. (2001) Cell biology and invasion of the microsporidia. 
Microbes and  Infection 3, 373-9. 
Blanshard C., Ellis D. S., Tovey D. G., Dowell S. and Gazzard B. G. (1992) Treatment 
of intestinal microsporidiosis with albendazole in patients with AIDS. Aids 6, 311-
3. 
Bryan R. T., Cali A., Owen R. L. and Spencer H. C. (1991) Microsporidia: opportunistic 
pathogens in patients with AIDS. Prog Clin Parasitol 2, 1-26. 
Bryan R. T. and Schwartz D. A. (1999) Epidemiology of microsporidiosis. In The 
microsporidia and microsporidiosis (Edited by Wittner M. and Weiss L. M.), p. 
502-530. ASM Press, Washington, DC. 
Buckholt M. A., Lee J. H. and Tzipori S. (2002) Prevalence of Enterocytozoon bieneusi 
in swine: an 18-month survey at a slaughterhouse in Massachusetts. Appl 
Environ Microbiol 68, 2595-9. 
Burri L., Williams B. A., Bursac D., Lithgow T. and Keeling P. J. (2006) Microsporidian 
mitosomes retain elements of the general mitochondrial targeting system. Proc 
Natl Acad Sci U S A 103, 15916-20. 
Cali A., Kotler D. P. and Orenstein J. M. (1993) Septata intestinalis N. G., N. Sp., an 
intestinal microsporidian associated with chronic diarrhea and dissemination in 
AIDS patients. J Eukaryot Microbiol 40, 101-12. 
Cali A. and Takvorian P. M. (1999) Developmental morphology and life cycles of the 
microsporidia. In The microsporidia and microsporidiosis (Edited by Wittner M. 
and Weiss L. M.), p. 85-128. ASM Press, Washington, DC. 
Cali A., Takvorian P. M., Lewin S., Rendel M., Sian C. S., Wittner M., Tanowitz H. B., 
Keohane E. and Weiss L. M. (1998) Brachiola vesicularum, n. g., n. sp., a new 
microsporidium associated with AIDS and myositis. J Eukaryot Microbiol 45, 240-
51. 
  29
Cama V. A., Pearson J., Cabrera L., Pacheco L., Gilman R., Meyer S., Ortega Y. and 
Xiao L. (2007) Transmission of Enterocytozoon bieneusi between a child and 
guinea pigs. J Clin Microbiol 45, 2708-10. 
Cavalier-Smith T. (1991) Archamoebae: the ancestral eukaryotes? Biosystems 25, 25-
38. 
Conteas C. N., Berlin O. G., Ash L. R. and Pruthi J. S. (2000) Therapy for human 
gastrointestinal microsporidiosis. Am J Trop Med Hyg 63, 121-7. 
Couzinet S., Cejas E., Schittny J., Deplazes P., Weber R. and Zimmerli S. (2000) 
Phagocytic uptake of Encephalitozoon cuniculi by nonprofessional phagocytes. 
Infection and Immunity 68, 6939-45. 
Coyle C. M., Weiss L. M., Rhodes L. V., 3rd, Cali A., Takvorian P. M., Brown D. F., 
Visvesvara G. S., Xiao L., Naktin J., Young E., Gareca M., Colasante G. and 
Wittner M. (2004) Fatal myositis due to the microsporidian Brachiola algerae, a 
mosquito pathogen. N Engl J Med 351, 42-7. 
Davis R. M., Font R. L., Keisler M. S. and Shadduck J. A. (1990) Corneal 
microsporidiosis. A case report including ultrastructural observations. 
Ophthalmology 97, 953-7. 
Desportes I., Le Charpentier Y., Galian A., Bernard F., Cochand-Priollet B., Lavergne 
A., Ravisse P. and Modigliani R. (1985) Occurrence of a new microsporidan: 
Enterocytozoon bieneusi n.g., n. sp., in the enterocytes of a human patient with 
AIDS. J Protozool 32, 250-4. 
Didier E. S. (1995) Reactive nitrogen intermediates implicated in the inhibition of 
Encephalitozoon cuniculi (phylum microspora) replication in murine peritoneal 
macrophages. Parasite Immunology 17, 405-12. 
Didier E. S. (1998) Microsporidiosis. Clin Infect Dis 27, 1-7; quiz 8. 
Didier E. S. (2005) Microsporidiosis: an emerging and opportunistic infection in humans 
and animals. Acta Tropica 94, 61-76. 
Didier E. S., Bertucci D. C., Green L. C., Stovall M. E. and Didier P. J. (2001) 
Encephalitozoon cuniculi infection in mice with the chronic granulomatous 
disease (CGD) disorder. The Journal of Eukaryotic Microbiology Suppl, 79S-
80S. 
  30
Didier E. S. and Bessinger G. T. (1999) Host-parasite relationships in microsporidiosis: 
Animal models and immunology. In The microsporidia and microsporidiosis 
(Edited by Wittner M. and Weiss L. M.), p. 225-257. ASM Press, Washington, 
DC. 
Didier E. S. and Shadduck J. A. (1994) IFN-gamma and LPS induce murine 
macrophages to kill Encephalitozoon cuniculi in vitro. The Journal of Eukaryotic 
Microbiology 41, 34S. 
Didier E. S., Stovall M. E., Green L. C., Brindley P. J., Sestak K. and Didier P. J. (2004) 
Epidemiology of microsporidiosis: sources and modes of transmission. Veterinary 
Parasitology 126, 145-66. 
Dieterich D. T., Lew E. A., Kotler D. P., Poles M. A. and Orenstein J. M. (1994) 
Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi 
in patients with AIDS. J Infect Dis 169, 178-83. 
Dowd S. E., John D., Eliopolus J., Gerba C. P., Naranjo J., Klein R., Lopez B., de Mejia 
M., Mendoza C. E. and Pepper I. L. (2003) Confirmed detection of Cyclospora 
cayetanesis, Encephalitozoon intestinalis and Cryptosporidium parvum in water 
used for drinking. J Water Health 1, 117-23. 
Dworkin M. S., Buskin S. E., Davidson A. J., Cohn D. L., Morse A., Inungu J., Adams M. 
R., McCombs S. B., Jones J. L., Moura H., Visvesvara G., Pieniazek N. J. and 
Navin T. R. (2007) Prevalence of intestinal microsporidiosis in human 
immunodeficiency virus-infected patients with diarrhea in major United States 
cities. Rev Inst Med Trop Sao Paulo 49, 339-42. 
El Fakhry Y., Achbarou A., Desportes I. and Mazier D. (2001) Resistance to 
Encephalitozoon intestinalis is associated with interferon-gamma and interleukin-
2 cytokines in infected mice. Parasite Immunol 23, 297-303. 
Enriquez E. J. (1997) Microsporidia: immunity and immunodiagnosis. In 2nd Workshop 
Microsporidiosis and Crytosporidiosis Immunodeficient Patients, p. 16, Ceske 
Budejovice, Czeh Republic. 
Enriquez F. J., Wagner G., Fragoso M. and Ditrich O. (1998) Effects of an anti-exospore 
monoclonal antibody on microsporidial development in vitro. Parasitology 117 ( 
Pt 6), 515-20. 
 
  31
Espern A., Morio F., Miegeville M., Illa H., Abdoulaye M., Meyssonnier V., Adehossi E., 
Lejeune A., Cam P. D., Besse B. and Gay-Andrieu F. (2007) Molecular study of 
microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon 
intestinalis among human immunodeficiency virus-infected patients from two 
geographical areas: Niamey, Niger, and Hanoi, Vietnam. J Clin Microbiol 45, 
2999-3002. 
Fasshauer V., Gross U. and Bohne W. (2005) The parasitophorous vacuole membrane 
of Encephalitozoon cuniculi lacks host cell membrane proteins immediately after 
invasion. Eukaryot Cell 4, 221-4. 
Field A. S., Marriott D. J., Milliken S. T., Brew B. J., Canning E. U., Kench J. G., 
Darveniza P. and Harkness J. L. (1996) Myositis associated with a newly 
described microsporidian, Trachipleistophora hominis, in a patient with AIDS. J 
Clin Microbiol 34, 2803-11. 
Franzen C. (2004) Microsporidia: how can they invade other cells? Trends Parasitol 20, 
275-9. 
Franzen C., Hartmann P. and Salzberger B. (2005a) Cytokine and nitric oxide 
responses of monocyte-derived human macrophages to microsporidian spores. 
Exp Parasitol 109, 1-6. 
Franzen C. and Muller A. (1999) Molecular techniques for detection, species 
differentiation, and phylogenetic analysis of microsporidia. Clin Microbiol Rev 12, 
243-85. 
Franzen C., Muller A., Hartmann P. and Salzberger B. (2005b) Cell invasion and 
intracellular fate of Encephalitozoon cuniculi (Microsporidia). Parasitology 130, 
285-92. 
Friedberg D. N., Stenson S. M., Orenstein J. M., Tierno P. M. and Charles N. C. (1990) 
Microsporidial keratoconjunctivitis in acquired immunodeficiency syndrome. Arch 
Ophthalmol 108, 504-8. 
Gill E. E. and Fast N. M. (2006) Assessing the microsporidia-fungi relationship: 
Combined phylogenetic analysis of eight genes. Gene 375, 103-9. 
Goldberg A. V., Molik S., Tsaousis A. D., Neumann K., Kuhnke G., Delbac F., Vivares 
C. P., Hirt R. P., Lill R. and Embley T. M. (2008) Localization and functionality of 
microsporidian iron-sulphur cluster assembly proteins. Nature. 
  32
Graczyk T. K., Sunderland D., Rule A. M., da Silva A. J., Moura I. N., Tamang L., 
Girouard A. S., Schwab K. J. and Breysse P. N. (2007) Urban feral pigeons 
(Columba livia) as a source for air- and waterborne contamination with 
Enterocytozoon bieneusi spores. Appl Environ Microbiol 73, 4357-8. 
Grove M. and Plumb M. (1993) C/EBP, NF-kappa B, and c-Ets family members and 
transcriptional regulation of the cell-specific and inducible macrophage 
inflammatory protein 1 alpha immediate-early gene. Mol Cell Biol 13, 5276-89. 
Hale-Donze H. and Didier E. (2007) Microsporidioses. In ENCYCLOPEDIA OF LIFE 
SCIENCES. John Wiley & Sons Ltd., Chichester. 
James S. L. (1995) Role of nitric oxide in parasitic infections. Microbiol Rev 59, 533-47. 
James T. Y., Kauff F., Schoch C. L., Matheny P. B., Hofstetter V., Cox C. J., Celio G., 
Gueidan C., Fraker E., Miadlikowska J., Lumbsch H. T., Rauhut A., Reeb V., 
Arnold A. E., Amtoft A., Stajich J. E., Hosaka K., Sung G. H., Johnson D., 
O'Rourke B., Crockett M., Binder M., Curtis J. M., Slot J. C., Wang Z., Wilson A. 
W., Schussler A., Longcore J. E., O'Donnell K., Mozley-Standridge S., Porter D., 
Letcher P. M., Powell M. J., Taylor J. W., White M. M., Griffith G. W., Davies D. 
R., Humber R. A., Morton J. B., Sugiyama J., Rossman A. Y., Rogers J. D., 
Pfister D. H., Hewitt D., Hansen K., Hambleton S., Shoemaker R. A., Kohlmeyer 
J., Volkmann-Kohlmeyer B., Spotts R. A., Serdani M., Crous P. W., Hughes K. 
W., Matsuura K., Langer E., Langer G., Untereiner W. A., Lucking R., Budel B., 
Geiser D. M., Aptroot A., Diederich P., Schmitt I., Schultz M., Yahr R., Hibbett D. 
S., Lutzoni F., McLaughlin D. J., Spatafora J. W. and Vilgalys R. (2006) 
Reconstructing the early evolution of Fungi using a six-gene phylogeny. Nature 
443, 818-22. 
Janeway C., Travers P., Walport M. and Shlomchik M. (2005) Immunobiology : the 
immune system in health and disease. Garland Science, New York. 
Jedrzejewski S., Graczyk T. K., Slodkowicz-Kowalska A., Tamang L. and Majewska A. 
C. (2007) Quantitative assessment of contamination of fresh food produce of 
various retail types by human-virulent microsporidian spores. Appl Environ 
Microbiol 73, 4071-3. 
Keeling P. J. (2003) Congruent evidence from alpha-tubulin and beta-tubulin gene 
phylogenies for a zygomycete origin of microsporidia. Fungal Genet Biol 38, 298-
309. 
  33
Keohane E. M. and Weiss L. M. (1999) The structure, function, and composition of the 
microsporidian polar tube. In The microsporidia and microsporidiosis (Edited by 
Wittner M. and Weiss L. M.), p. 196-224. ASM Press, Washington, D.C. 
Khan I. A. and Moretto M. (1999) Role of gamma interferon in cellular immune response 
against murine Encephalitozoon cuniculi infection. Infect Immun 67, 1887-93. 
Khan I. A., Schwartzman J. D., Kasper L. H. and Moretto M. (1999) CD8+ CTLs are 
essential for protective immunity against Encephalitozoon cuniculi infection. J 
Immunol 162, 6086-91. 
Kolter D. P. and Orenstein J. M. (1999) Clinical syndromes associated with 
microsporidiosis. In The microsporidia and microsporidiosis (Edited by Wittner M. 
and Weiss L. M.), p. 258-292. ASM Press, Washington, DC. 
Kotler D. P. and Orenstein J. M. (1998) Clinical syndromes associated with 
microsporidiosis. Adv Parasitol 40, 321-49. 
Kunsch C. and Rosen C. A. (1993) NF-kappa B subunit-specific regulation of the 
interleukin-8 promoter. Mol Cell Biol 13, 6137-46. 
Laing K. J. and Secombes C. J. (2004) Chemokines. Dev Comp Immunol 28, 443-60. 
Ledford D. K., Overman M. D., Gonzalvo A., Cali A., Mester S. W. and Lockey R. F. 
(1985) Microsporidiosis myositis in a patient with the acquired immunodeficiency 
syndrome. Ann Intern Med 102, 628-30. 
Lee J. H. (2008) Molecular detection of Enterocytozoon bieneusi and identification of a 
potentially human-pathogenic genotype in milk. Appl Environ Microbiol 74, 1664-
6. 
Leelayoova S., Subrungruang I., Rangsin R., Chavalitshewinkoon-Petmitr P., Worapong 
J., Naaglor T. and Mungthin M. (2005) Transmission of Enterocytozoon bieneusi 
genotype a in a Thai orphanage. Am J Trop Med Hyg 73, 104-7. 
Lores B., Lopez-Miragaya I., Arias C., Fenoy S., Torres J. and del Aguila C. (2002) 
Intestinal microsporidiosis due to Enterocytozoon bieneusi in elderly human 
immunodeficiency virus--negative patients from Vigo, Spain. Clin Infect Dis 34, 
918-21. 
Margileth A. M., Strano A. J., Chandra R., Neafie R., Blum M. and McCully R. M. (1973) 
Disseminated nosematosis in an immunologically compromised infant. Arch 
Pathol 95, 145-50. 
  34
Marshall M. M., Hayes S., Moffett J., Sterling C. R. and Nicholson W. L. (2003) 
Comparison of UV inactivation of spores of three encephalitozoon species with 
that of spores of two DNA repair-deficient Bacillus subtilis biodosimetry strains. 
Appl Environ Microbiol 69, 683-5. 
Matsubayashi H., Koike T., Mikata I., Takei H. and Hagiwara S. (1959) A case of 
Encephalitozoon-like body infection in man. AMA Arch Pathol 67, 181-7. 
McInnes E. F. and Stewart C. G. (1991) The pathology of subclinical infection of 
Encephalitozoon cuniculi in canine dams producing pups with overt 
encephalitozoonosis. J S Afr Vet Assoc 62, 51-4. 
Medzhitov R. (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1, 135-
45. 
Medzhitov R. (2007) Recognition of microorganisms and activation of the immune 
response. Nature 449, 819-26. 
Metchnikov E. (1884) Uber eine sprosspilzkrankheit der daphnien. Beitrag zur lehre 
uber den kampf der phagocyten gegen krankheitserreger. Virchows Arch 96, 
177-195. 
Molina J. M., Goguel J., Sarfati C., Chastang C., Desportes-Livage I., Michiels J. F., 
Maslo C., Katlama C., Cotte L., Leport C., Raffi F., Derouin F. and Modai J. 
(1997) Potential efficacy of fumagillin in intestinal microsporidiosis due to 
Enterocytozoon bieneusi in patients with HIV infection: results of a drug 
screening study. The French Microsporidiosis Study Group. Aids 11, 1603-10. 
Moretto M., Casciotti L., Durell B. and Khan I. A. (2000) Lack of CD4(+) T cells does not 
affect induction of CD8(+) T-cell immunity against Encephalitozoon cuniculi 
infection. Infect Immun 68, 6223-32. 
Niederkorn J. Y. and Shadduck J. A. (1980) Role of antibody and complement in the 
control of Encephalitozoon cuniculi infections by rabbit macrophages. Infect 
Immun 27, 995-1002. 
Nkinin S. W., Asonganyi T., Didier E. S. and Kaneshiro E. S. (2007) Microsporidian 
infection is prevalent in healthy people in Cameroon. J Clin Microbiol 45, 2841-6. 
Omura M., Furuya K., Kudo S., Sugiura W. and Azuma H. (2007) Detecting 
immunoglobulin M antibodies against microsporidian Encephalitozoon cuniculi 
polar tubes in sera from healthy and human immunodeficiency virus-infected 
persons in Japan. Clin Vaccine Immunol 14, 168-72. 
  35
Orenstein J. M. (2003) Diagnostic pathology of microsporidiosis. Ultrastruct Pathol 27, 
141-9. 
Pinnolis M., Egbert P. R., Font R. L. and Winter F. C. (1981) Nosematosis of the 
cornea. Case report, including electron microscopic studies. Arch Ophthalmol 99, 
1044-7. 
Rosberger D. F., Serdarevic O. N., Erlandson R. A., Bryan R. T., Schwartz D. A., 
Visvesvara G. S. and Keenan P. C. (1993) Successful treatment of microsporidial 
keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 12, 261-
5. 
Sagoo M. S., Mehta J. S., Hau S., Irion L. D., Curry A., Bonshek R. E. and Tuft S. J. 
(2007) Microsporidium stromal keratitis: in vivo confocal findings. Cornea 26, 
870-3. 
Sak B. and Ditrich O. (2005) Humoral intestinal immunity against Encephalitozoon 
cuniculi (Microsporidia) infection in mice. Folia Parasitol (Praha) 52, 158-62. 
Sak B., Salat J., Horka H., Sakova K. and Ditrich O. (2006) Antibodies enhance the 
protective effect of CD4+ T lymphocytes in SCID mice perorally infected with 
Encephalitozoon cuniculi. Parasite Immunol 28, 95-9. 
Salat J., Jelinek J., Chmelar J. and Kopecky J. (2008) Efficacy of interferon gamma and 
specific antibody for treatment of microsporidiosis caused by Encephalitozoon 
cuniculi in SCID mice. Antimicrob Agents Chemother. 
Santillana-Hayat M., Sarfati C., Fournier S., Chau F., Porcher R., Molina J. M. and 
Derouin F. (2002) Effects of chemical and physical agents on viability and 
infectivity of Encephalitozoon intestinalis determined by cell culture and flow 
cytometry. Antimicrob Agents Chemother 46, 2049-51. 
Schmidt E. C. and Shadduck J. A. (1983) Murine encephalitozoonosis model for 
studying the host-parasite relationship of a chronic infection. Infect Immun 40, 
936-42. 
Schmidt E. C. and Shadduck J. A. (1984) Mechanisms of resistance to the intracellular 
protozoan Encephalitozoon cuniculi in mice. J Immunol 133, 2712-9. 
Sharpstone D., Rowbottom A., Francis N., Tovey G., Ellis D., Barrett M. and Gazzard B. 
(1997) Thalidomide: a novel therapy for microsporidiosis. Gastroenterology 112, 
1823-9. 
  36
Soule J. B., Halverson A. L., Becker R. B., Pistole M. C. and Orenstein J. M. (1997) A 
patient with acquired immunodeficiency syndrome and untreated 
Encephalitozoon (Septata) intestinalis microsporidiosis leading to small bowel 
perforation. Response to albendazole. Arch Pathol Lab Med 121, 880-7. 
Takeda K. and Akira S. (2005) Toll-like receptors in innate immunity. Int Immunol 17, 1-
14. 
Teferedegne B., Green M. R., Guo Z. and Boss J. M. (2006) Mechanism of action of a 
distal NF-kappaB-dependent enhancer. Mol Cell Biol 26, 5759-70. 
Thomarat F., Vivares C. P. and Gouy M. (2004) Phylogenetic analysis of the complete 
genome sequence of Encephalitozoon cuniculi supports the fungal origin of 
microsporidia and reveals a high frequency of fast-evolving genes. J Mol Evol 59, 
780-91. 
Tumwine J. K., Kekitiinwa A., Bakeera-Kitaka S., Ndeezi G., Downing R., Feng X., 
Akiyoshi D. E. and Tzipori S. (2005) Cryptosporidiosis and microsporidiosis in 
ugandan children with persistent diarrhea with and without concurrent infection 
with the human immunodeficiency virus. Am J Trop Med Hyg 73, 921-5. 
Underhill D. M. and Ozinsky A. (2002) Phagocytosis of microbes: complexity in action. 
Annu Rev Immunol 20, 825-52. 
Vavra J. and Larsson J. I. R. (1999) Structure of the microsporidia. In The microsporidia 
and microsporidiosis (Edited by Wittner M. and Weiss L. M.), p. 7-84. ASM 
Press, Washington, D.C. 
Visvesvara G. S., Belloso M., Moura H., Da Silva A. J., Moura I. N., Leitch G. J., 
Schwartz D. A., Chevez-Barrios P., Wallace S., Pieniazek N. J. and Goosey J. D. 
(1999) Isolation of Nosema algerae from the cornea of an immunocompetent 
patient. J Eukaryot Microbiol 46, 10S. 
Wasson K. and Peper R. L. (2000) Mammalian microsporidiosis. Vet Pathol 37, 113-28. 
Weidner E. (1975) Interactions between Encephalitozoon cuniculi and macrophages. 
Parasitophorous vacuole growth and the absence of lysosomal fusion. Z 
Parasitenkd 47, 1-9. 
Weiss L. M. (2001) Microsporidia: emerging pathogenic protists. Acta Trop 78, 89-102. 
 
  37
Widmer U., Manogue K. R., Cerami A. and Sherry B. (1993) Genomic cloning and 
promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and 
MIP-1 beta, members of the chemokine superfamily of proinflammatory 
cytokines. J Immunol 150, 4996-5012. 
Williams B. A., Hirt R. P., Lucocq J. M. and Embley T. M. (2002) A mitochondrial 
remnant in the microsporidian Trachipleistophora hominis. Nature 418, 865-9. 
Wittner M. (1999) Historic perspective on the microsporidia: expanding horizons. In The 
microsporidia and microsporidiosis (Edited by Wittner M. and Weiss L. M.), p. 1-
6. ASM Press, Washington, D.C. 
Wright J. H. and Craighead E. M. (1922) Infectious motor paralysis in young rabbits. J 
Exp. Med. 36, 135-149. 
Yachnis A. T., Berg J., Martinez-Salazar A., Bender B. S., Diaz L., Rojiani A. M., Eskin 
T. A. and Orenstein J. M. (1996) Disseminated microsporidiosis especially 
infecting the brain, heart, and kidneys. Report of a newly recognized 
pansporoblastic species in two symptomatic AIDS patients. Am J Clin Pathol 
106, 535-43. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  38
CHAPTER 2 
KINETICS OF ENCEPHALITOZOON SPP. INFECTION OF HUMAN 
MACROPHAGES∗ 
 
Introduction 
 For many years, microsporidians have been recognized as pathogens of 
invertebrate and vertebrate species, including silkworms, honeybees, mosquitoes, mice, 
rabbits, foxes, pigs, and cows (Didier et al., 2004; Weiss, 2001), but have only recently 
gained greater notoriety for their ability to cause chronic and fatal disseminated 
infections in humans diagnosed with HIV/AIDS or in patients on immunosuppressive 
therapies (Carlson et al., 2004; Didier et al., 2004; Orenstein, 2003; Schottelius and da 
Costa, 2000).  Of the more than 1,200 microsporidian species, only 14 have been 
reported to infect humans (Didier et al., 2004).  When left untreated, 
immunocompromised patients suffer from chronic diarrhea, leading to dehydration and 
malnutrition.  Often, in these patients, disseminated disease has been reported to cause 
keratoconjunctivitis, sinusitis, tracheobronchitis, encephalitis, interstitial nephritis, 
hepatitis, cholecystitis, osteomyelitis, and myositis (Didier, 2005; Orenstein, 2003; 
Schottelius and da Costa, 2000). 
 Microsporidians are obligate intracellular, eukaryotic parasites that were once 
classified as protozoans, but are now suggested to be more closely related to fungi, 
based on phylogenetic analysis (Gill and Fast, 2006). Microsporidians are found 
worldwide and are shed in the feces and urine of infected animals, thereafter, residing 
as environmentally resistant spores.  Microsporidian infections are believed to occur 
                                                            
∗ Reprinted from Journal of Parasitology, Vol 94(1), J. Fischer, D. Tran, R. Juneau, and H. Hale-Donze, 
Kinetics of Encephalitozoon spp. Infection of Human Macrophages, Pages 169-175, Copyright 2008, with 
permission from American Society of Parasitologists. 
  39
when the spore is ingested from contaminated water or food sources (Didier et al., 
2004).  Infections of epithelial and endothelial cells and macrophages are common 
(Khan et al., 2001).  Classically, cellular invasion occurs when the spore encounters a 
host cell and everts a polar tube, thereby penetrating the cell membrane and injecting 
the sporoplasm.  Alternatively, spores can be internalized through phagocytosis or 
endocytosis.  Further proliferation and spore production occur through merogony and 
sporogony within a parasitophorous vacuole (PV), followed by lysis of the host cell and 
release of mature spores (Franzen, 2004). 
 The microsporidians, Encephalitozoon spp., have been described in several case 
reports that have culminated in disseminated infections (Carlson et al., 2004; 
Gunnarsson et al., 1995; Soule et al., 1997) and have been reported as having a 
promiscuous tropism for a variety of mammalian tissues and cell lines (Visvesvara, 
2002).  Some reports have suggested that dissemination is the result of migrating 
macrophages that act as reservoirs and allow for the vehicular dispersal of the parasite, 
all the while providing host metabolites for their replication (Fischer et al., 2007; 
Orenstein, 2003; Soule et al., 1997).  To elucidate the role of macrophages in 
microsporidiosis including dissemination events, it is critical to establish the timing of 
parasitic entry, replication, and lysis in primary human macrophages. The infection 
kinetics and production of mature spores have been well established in several non-
human cell lines and animal models (Cox et al., 1979; Didier et al., 2001; Gannon, 
1980; Salat et al., 2001; Wasson and Barry, 2003), whereas, most studies on infection 
kinetics in human cell lines and primary cells are limited (Couzinet et al., 2000; 
Fasshauer et al., 2005; Franzen et al., 2005a; Franzen et al., 2005b; Franzen et al., 
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2005c; Leitch et al., 2005).  While these studies suggest that a variety of cell types can 
act as permissive hosts for microsporidian replication, the role of primary human 
macrophages in these infections is not well defined. 
Studies on infections of murine models with Encephalitozoon spp. have 
described methods of parasitic evasion in macrophages (Weidner, 1975) and the 
consequent increase of mature spores (Didier and Shadduck, 1994) which suggests 
that parasite replication is capable in these cells. Furthermore, it was established that 
host resistance to the parasite could be induced by supplementing the cells with 
interferon-gamma (IFN-γ) or tumor necrosis factor-alpha (TNF-α) (Didier and Shadduck, 
1994; Khan and Moretto, 1999), which lead to the subsequent release of reactive 
nitrogen intermediates that contributed to the success of parasitic killing (Didier, 1995).  
 Recently, studies conducted on Encephalitozoon spp. infections of resting 
human macrophages reported elevated levels of various cytokines needed for 
pathogenic clearance, i.e., IFN-γ, TNF-α, however failed to detect increases in nitric 
oxide that may lead to microbial killing (Franzen et al., 2005a).  Further  investigations 
determining the kinetics of infection in primary human macrophages showed that these 
infections did not result in the production of mature spores when followed for 12 days 
(Franzen et al., 2005c).  However, in the discussion and subsequent review, it was 
proposed that parasites could escape from the phagolysosome yielding a productive 
infection (Franzen, 2005; Franzen et al., 2005c).  Taken together, these studies suggest 
that microsporidians activate resting macrophages to become microbicidal and do not 
allow for the pathogen to gain an intracellular stronghold.  Both human and murine 
studies of infection agree that pathogenic clearance is mediated through the induction of 
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cytokines, such as IFN-γ and TNF-α; however, the same studies disagree about the 
likelihood of Encephalitozoon spp. directly activating resting macrophages to invoke the 
microbicidal response. 
 Using 3 different methods to identify the adherence and uptake of the spore, the 
active replicating stages of the vegetative meronts and the formation of PV, the present 
study uniquely defines the life cycle for Encephalitozoon spp. in primary human 
macrophages.  Additionally, we confirm the role for IFN-γ and bacterial 
lipopolysaccharide (LPS) treatment of resting human macrophages in reducing parasite 
replication. 
Materials and Methods 
Cell Culture.  Peripheral blood mononuclear cells (PBMC) were isolated from 
buffy coats from healthy donors (Our Lady of the Lake Regional Medical Center, Baton 
Rouge, Louisiana) by gradient centrifugation on lymphocyte separation media 
(Cambrex, Walkersville, Maryland).  Monocyte-derived-macrophages (MDM) were 
obtained by adherence assays, as previously reported (Fischer et al., 2007). Briefly, 
monocytes were plated onto 12-well culture plates (1 x 106 monocytes/well), containing 
coverglasses, (Greiner Bio-One, Cellstar, Monroe, North Carolina) and cultured for 3 hr 
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 2 mM L-glutamine, 
100 U/ml penicillin, 100 µg/ml streptomycin, and 0.1 µg/ml gentamicin at 37 °C in 5% 
CO2. Cells were stringently washed with PBS to remove non-adhered PBMC and then 
allowed to differentiate for 7 days in complete media with 10% fetal calf serum (FCS) 
(Cambrex) at 37 °C in 5% CO2. Unless stated, all tissue culture media was purchased 
from VWR (West Chester, Pennsylvania). 
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Parasites.  Encephalitozoon cuniculi III and E. intestinalis (a generous gift from 
Elizabeth Didier, Tulane National Primate Research Center, Covington, LA) were grown 
in a rabbit kidney cell line (ATCC CCL-37) and harvested from tissue culture 
supernatants.  Spores were washed once in PBS containing 0.2% Tween-20, 
resuspended in supplemented DMEM, and counted with a hemacytometer (Didier et al., 
1991). Some spores were inactivated by treatment with 10% bleach solution for 30 min 
and washed once with water, while others were heat-inactivated in a 95 °C water bath 
for 30 min.  Spores were used at a 5:1 spore-to-MDM ratio (Fischer et al., 2007), and 
infected cultures were washed free of unadhered spores at 6 hr and maintained at 37 °C 
in 5% CO2. 
Scanning Electron Microscopy (SEM).  SEM was used to monitor immediate 
adherence of spores to MDM.  Cells grown on culture plates were challenged with 
spores of E. intestinalis for 5 min and fixed with 2% glutaraldehyde and 1% 
formaldehyde in 0.75% sucrose and 0.1 M sodium cacodylate buffer for 1 hr; washed 4 
times with 1.5% sucrose and 0.02 M glycine in 0.1 M sodium cacodylate buffer; post-
fixed with 2% osmium tetroxide for 1 hr and rinsed with distilled water.  Cells were 
dehydrated with a graded series of ethanol and air dryed.  Well bottoms were cut from 
culture dishes and mounted on aluminum specimen holders with conductive tape, 
coated with gold/palladium (60/40) in an Edwards S-150 sputter coater, and imaged 
with a Cambridge S-260 SEM. 
Adherence, Uptake, and Proliferation Assays.  Kinetics of adherence and 
uptake were measured by enumerating macrophages that were positive for spores and 
contained a peri-nuclear parasitophorous vacuole (PV) of spores, respectively.  In 
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adherence assays, macrophages were challenged with spores for 1, 3, or 6 hr, washed 
with PBS and fixed in methanol for 10 min.  Cells were stained with a 0.2% solution of 
SCRI Renaissance Stain 2200 chitin label (Renaissance Chemicals Ltd., North 
Yorkshire, U.K.) for 20 min at room temperature to allow for visualization of the spores.  
Coverglasses were mounted in Prolong Gold antifade reagent with DAPI (Invitrogen, 
Carlsbad, California).  MDM with fluorescent blue spores attached were counted. 
In uptake assays, spores were pre-labeled with PKH26 Fluorescent Cell Linker, 
per manufacturer’s instructions, (Sigma, St. Louis, Missouri).  MDM were challenged for 
3, 6, 12, 24, 48, or 72 hr.  MDM challenged for 3 hr were washed of free spores and 
fixed.  All other cultures were washed with PBS at 6 hr post-challenge to remove free 
spores.  Cells were fixed in 10% formalin for 30 min and coverglasses were mounted in 
Prolong Gold antifade reagent with DAPI to detect nuclear staining of MDM.  MDM with 
peri-nuclear organized vacuoles of red spores were counted.  
Microsporidia proliferation and infection were monitored using the 
bromodeoxyuridine (BrdU) assay system (Invitrogen).  MDM were challenged with 
spores for 24, 48, 72, 120, 168, or 240 hr and fixed in 4% paraformaldehyde.  Free 
spores were washed from cultures with PBS at 6 hr post-infection (PI) and media was 
replaced.  Twenty-four hr prior to fixation, 100 µM of BrdU was added to each well.  
Cells were washed with 1% Triton X-100 and treated with 1 N HCl for 10 min on ice, 2 N 
HCl for 10 min at room temperature, and 2 N HCl for 20 min at 37 °C.  Cells were 
neutralized in a 0.1 M borate buffer and washed with 1% Triton X-100.   MDM were 
incubated on ice with a 1/50 dilution of Alexa Fluor 488 anti-BrdU (Invitrogen) in 0.5% 
bovine serum albumin and 1% Triton X-100 for 90 min.  Cells were washed with 1% 
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Triton X-100 and mounted in Prolong Gold antifade reagent.  In some cultures, MDM 
were stimulated with various concentrations of human recombinant IFN-γ (eBioscience, 
San Diego, California) or LPS (Sigma) 24 hr prior to spore challenge.  MDM containing 
green fluorescent vacuoles of replicating parasite were counted. 
The kinetics of spore production was monitored with Differential Interference 
Contrast (DIC) microscopy by counting MDM that contained mature parasitophorous 
vacuoles of spores. 
Ten fields of view with an average number of 115 MDM per experiment were 
counted with a 63x objective in all assays, unless otherwise stated.  Cells were viewed 
using a Leica DMI 6000 B inverted fluorescence microscope, and captured and 
analyzed with a Leica DFX300 FX CCD camera and Image Pro Plus v5.1 software 
(MediaCybernetics, Silver Spring, Maryland). 
Statistical Analysis.  Three experiments were performed at each time point and 
for each parasite or condition, unless otherwise stated.  Each experiment consisted of a 
single donor and was measured in duplicate.  Statistical significance was determined by 
the unpaired, 2-tailed t-test, and values of P ≤ 0.05 were considered significant.  All 
error bars shown in this paper are SEM.  Analyses were performed using InStat 
software (GraphPad 3.0, San Diego, California). 
Results 
Encephalitozoon spp. Rapidly Adhere to Macrophages and Are Internalized 
by a Majority of the Cells within the First 24-48 hr.  Spore adherence to 
macrophages is a rapid process as seen by SEM.  MDM exposed to E. intestinalis 
spores for 5 min prior to fixation and mounting demonstrate that minimal time was 
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needed for some of the cells to acquire several spores on their surface (Fig. 2.1A).  
Typically, aggregates of spores were seen bound on MDM, which suggests that cells 
may cluster specific surface molecules needed for microsporidia adherence (Fig. 2.1B).  
Host membranes were observed intimately associated with the spores. 
 
Figure 2.1  Scanning electron micrographs of spores attached to macrophages.  
SEM was used to monitor the immediate attachment of spores to MDM.  Cells were 
exposed to E. intestinalis spores for 5 min prior to fixation and mounting for SEM.  (A) 
The rapid association between spores and macrophages is observed as clusters of 
spores attach to the pseudopodia of this macrophage (bar = 5 µm).  (B) Spores 
immediately contact the host cell and are rapidly surrounded by cell membrane (arrow) 
(bar = 2 µm). 
 
Using fluorescence microscopy, we established that MDM exposure to spores for 
6 hr is required to generate greater than 75% of MDM with adhered spores.  Cells 
cultured with E. cuniculi or E. intestinalis for 1, 3, or 6 hr were washed free of spores, 
fixed, and stained with a fluorescent chitin label to visualize the spore wall (Fig. 2.2A).  
Nearly 50% of MDM had at least 1 spore attached after only 1 hr of challenge with 
either species (Fig. 2.2B).  The percentage of MDM with attached spores and the 
number of spores per macrophage (Fig. 2.2C) continued to increase over time up to 6 
hr.  At 6 hr, approximately 79% of MDM showed adherence of E. cuniculi, while 85% of 
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Figure 2.2  Kinetics of spore adherence.  MDM challenged with spores of E. cuniculi 
or E. intestinalis were fixed and treated with DAPI nuclear stain to visualize MDM 
nucleus (blue,n) and a chitin stain to label endospores (blue, arrows) at various times.  
DIC and fluorescent images were captured at 630x and merged (A).  MDM positive for 
spores were counted to determine the kinetics of adherence.  Both species of parasites 
showed similar rates of adherence with greater than 75% of MDM staining positive for 
spores at 6 hr post-challenge (B).  The average number of spores per MDM resulted in 
a greater accumulation of spores by 6 hr for both species (C). 
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cells were positive for E. intestinalis.  The average number of spores per macrophage 
observed at 6 hr was approximately 11 and 17 for E. cuniculi and E. intestinalis, 
respectively.  However, some MDM did not have any spores attached.  This suggests 
that a population of MDM may be present that does not express a surface molecule 
needed for immediate attachment.  These initial results determined that greater than 
75% of MDM would have attached spores after 6 hr of exposure.  Therefore, in all 
performed experiments, non-adhered spores were washed out at this time point, unless 
otherwise stated. 
To monitor the kinetics of microsporidian uptake, MDM were challenged with 
spores pre-labeled with an amphipathic lipid fluorescent dye that binds plasma 
membranes and allows one to follow the parasitic membranes during intracellular 
development.  In previous reports that studied kinetics (Couzinet et al., 2000; Didier and 
Shadduck, 1994; Franzen et al., 2005c), parasites have been detected with fluorescent 
chemicals or antibodies directed against the spore coat, which is subsequently removed 
or lost during parasite replication.  MDM were monitored for peri-nuclear vacuoles 
containing red labeled spores at various times (Fig. 2.3A).  By 6 hr PI (Fig. 2.3B), 
approximately 27% of MDM contained vacuoles and demonstrated minor increases in 
uptake at 12 hr and 24 hr.  Comparison of uptake data at time points consecutive to 
each other revealed significant increases in spore uptake occurring at both 48 hr and 72 
hr, with 56% and 69% of MDM observed to contain labeled vacuoles, respectively. 
Pronounced Replication of E. cuniculi in MDM Begins at 72 hr PI.  MDM 
infected with E. cuniculi spores at various times were observed for microsporidia 
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Figure 2.3  Kinetics of spore uptake.  MDM challenged with pre-labeled E. cuniculi 
spores (red) were observed for peri-nuclear, organized vacuole formation and counted 
to determine the kinetics of uptake.  All cultures were washed free of unattached spores 
by 6 hr post-challenge, except for 3 hr cultures, which were washed at this time.  MDM 
were fixed at various time points and stained with DAPI, a nuclear label (blue).  Images 
were analyzed at 400x magnification, which allows for determining between MDM with 
and without spore vacuoles (A). The percentage of MDM containing red vacuoles of 
spores continuously increased from 3 hr through to 72 hr post-challenge (B), resulting in 
greater than 50% of MDM with spores by 48 hr and almost 70% by 72 hr. 
 
replication using the BrdU assay.  The nucleotide analog (BrdU) was added to infected 
cultures 24 hr prior to fixation, and stained with an anti-BrdU antibody conjugated to a 
fluorescent dye, to visualize vacuoles of replicating parasites (Fig. 2.4A).  MDM are 
terminally differentiated cells and therefore, do not incorporate BrdU into the DNA, 
whereas the actively replicating meront stage of the parasite will utilize this nucleotide.  
Little replication was observed at 24 hr and 48 hr, while approximately 32% and 34% of 
MDM were positive for vacuoles with BrdU labeling at 72 hr and 120 hr, respectively 
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(Fig. 2.4B).  By 168 hr and 240 hr, a majority of the cells contained replicating vacuoles 
of microsporidians as detected by BrdU labeling. 
  
 
Figure 2.4  Replication of microsporidia in human macrophages.  Encephalitozoon 
cuniculi kinetics of replication in human macrophages was measured by the 
incorporation and detection of BrdU.  DIC and fluorescent images were visualized at 
630x magnification and merged to show peri-nuclear microsporidian replication (A).  At 
72 hr PI (B), approximately 32% of MDM were observed as containing vacuoles of 
fluorescent green replicating microsporidians (n=5).  DIC microscopy revealed MDM to 
contain mature vacuoles of newly created spores (C).  A significant percentage of MDM 
were observed to contain spores at 120 hr (D).  Arrows indicate parasite vacuoles, n 
represents host cell nucleus. 
 
The production of mature spores is analogous with the formation of mature PV 
containing easily identifiable spores by light microscopy.  Using DIC microscopy, MDM 
that contained PV with mature spores were counted at various times (Figs. 2.4C-D).  By 
120 hr, 15% of MDM contained vacuoles of spores, increasing to 27% and 22% by 168 
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hr and 240 hr, respectively.  It was first noted that a modest amount of MDM appeared 
to have ruptured and were releasing spores by 168 hr and was also observed at 240 hr.  
The release of spores and destruction of the MDM could account for an unexpected 
lower percentage of cells containing mature PV.  This also signifies the end of one 
round of the life cycle. 
In control studies, some MDM were infected with chlorine treated or heat-
inactivated E. cuniculi spores in which approximately 1% of MDM stained positive for 
chlorine treated spores and 1.6% for heat-inactivated spores at 72 hr.  These positive 
results from the chlorine treated and heat-inactivated studies could be attributed to 
minor emissions of cellular auto-fluorescence.  The production of mature PV was not 
observed in either treatment. 
Replication Kinetics of Encephalitozoon spp. Are Similar in MDM.  To 
determine if both species of microsporidians are able to replicate in MDM and have 
similar kinetics of infection, MDM were infected with E.  intestinalis and observed for 
proliferation using the BrdU assay.  Like E. cuniculi, E. intestinalis was able to replicate 
and complete sporogony as evaluated by PV formation in human MDM.   Approximately 
26% of the MDM were positive for replicating parasites at 72 hr and this number 
increased to 47% of cells by 120 hr.  The BrdU incorporation for E. intestinalis  was 
statistically significant from that reported for E. cuniculi at 120 hrs, however, the percent 
of cells with E. intestinalis PV did not differ at the same time point (Table 2.1). 
MDM Treated with IFN-γ and LPS Decrease Microsporidia Replication.  To 
determine if treatment of MDM with compounds known to increase intracellular killing 
 
  51
Table 2.1  Comparison of replication kinetics between Encephalitozoon spp. 
 % MDM BrdU Positive % MDM with P.V. 
 72 hr 120 hr 72 hr 120 hr 
E. cuniculi 32.43 ± 3.55 34.03 ± 1.52 1.98 ± 0.94 15.47 ± 2.14 
E. intestinalis 26.17 ± 1.74 47.45 ± 3.03* 6.28 ± 2.54 16.22 ± 5.61 
  *P < 0.05 in comparison to E. cuniculi at 120 hr 
 
 
could decrease replication events of microsporidians, IFN-γ and LPS were added to 
MDM cultures at various doses, independently and in combination, 24 hr prior to 
infection with E. cuniculi spores (Fig. 2.5).  Cells on coverglasses were stained for BrdU 
incorporation to determine the percentage of MDM containing replicating microsporidian 
vacuoles.  Treatment of MDM with IFN-γ yielded modest, but not statistically significant 
decreases of replicating parasites in host cells with concentrations of 10, 100, and 1,000 
U/ml.  Comparable results were observed when MDM were treated with 10, 100, and 
1,000 ng/ml of LPS.  In experiments where MDM were treated with either IFN-γ or LPS 
alone, a noticeable decrease in replication was observed when concentrations of 100 
U/ml or 100 ng/ml, respectively, were added to cultures.  Therefore, some MDM 
cultures were pre-treated with a combination of the compounds at these specific 
concentrations.  This resulted in nearly a 44% decrease in MDM that contained 
replicating microsporidians in comparison to E. cuniculi infected MDM cells not exposed 
to IFN-γ and LPS, which confirms that these pro-inflammatory mediators help induce a 
resistant environment with subsequent reduction in parasitic proliferation. 
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Figure 2.5  Reduction of E. cuniculi replication.  IFN-γ and LPS activation of MDM 
decreased the percentage of MDM with replicating E. cuniculi.  MDM were stimulated 
with IFN-γ and LPS for 24 hr prior to infection with spores of E. cuniculi.  Modest 
decreases in replication were observed when MDM were treated with IFN-γ or LPS 
independently; however, a significant decrease was seen in MDM treated with both IFN-
γ (100U/ml) and LPS (100ng/ml). 
 
Discussion 
Macrophages have been described as essential players for parasitic clearance in 
many model systems and for various pathogens (James, 1995). Resting macrophages 
require signals from Th1 cells, such as IFN-γ and CD40L, which result in their activation 
and increased intracellular microbicidal effects (Janeway et al., 2005).  Cases of 
microsporidiosis in HIV/AIDS patients and organ recipients receiving 
immunosuppressive therapies, who have significantly lower numbers of T cells, report 
that full clearance of the pathogen is difficult, and in some cases impossible, leading to 
dissemination and death (Salat et al., 2001; Schottelius and da Costa, 2000; Soule et 
al., 1997).  In our system, Encephalitozoon spp. could successfully exploit the host 
surface molecules and intracellular environment of human macrophages in the absence 
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of Th1 activation signals, and achieve a productive infection resulting in the 
accumulation of mature spores. 
To address critical questions about infection dynamics within a larger population 
and to establish a more defined time between spore attachment and parasitophorous 
vacuole formation, this study has used different approaches to better define the 
infectious process in primary human macrophages.  Prior methods to detect the spore 
coat with UV brighteners or antibodies are problematic in that the sporoplasm will 
eventually dissociate from the spore coat to undergo merogony. Because the meront 
stage has only previously been shown using TEM, limited information about the total 
population dynamics could be addressed.  This study, using a variety of methods, 
specifically addresses the need to determine adherence, uptake, replication, and spore 
formation in primary human macrophage, as no clear kinetics/methods have been 
established for following the infectious process, which is critical for looking at immune 
parameters related to entry versus replication. 
Our results indicate that spore adherence to the host cell is a rapid process, as 
adherence could be detected by SEM within 5 min after exposure of MDM to spores 
(Fig. 2.1) and three-quarters or more of MDM were adorned with numerous 
microsporidia by 6 hr post-challenge (Fig. 2.2).  This work is in agreement with several 
other research groups (Couzinet et al., 2000; Franzen et al., 2005b; Leitch et al., 2005), 
that have reported that spore uptake is a rapid, actin-dependent process.  Additionally, 
we observed a subset of macrophages that did not contain any spores on their surface, 
which may represent a population of cells that do not express a surface molecule 
required for spore adherence.  Recently, Hayman et al. (2005), has shown that spore 
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adherence can be mediated by the expression of sulfated glycosaminoglycans, 
specifically, heparan sulfate, which has been established as an abundant component of 
the activated human MDM cell surface (Clasper et al., 1999).  Based on these reports, 
the disparity in number of spores we observed in association with MDM may reflect the 
activation status of the cells. 
In experiments with pre-labeled spores, we looked to define the amount of MDM 
present that contained organized vacuoles of microsporidia and were peri-nuclear in the 
host cell at various times (Fig. 2.3).  Similar to Franzen et al. (2005c), greater than 30% 
of MDM were observed to contain these vacuoles at 24 hr PI.  In contrast to Franzen et 
al. (2005c) results, which show that the number of MDM internalized spores decreases 
over the next 48 hr and that new developing parasites were not observed for the 
remainder of a 12-day infection, we report that 50% of MDM contain vacuoles of the 
parasite between 24-48 hr and nearly 70% at 72 hr.  This discrepancy could be due to 
our differences in staining techniques used to follow the parasite’s uptake and 
intracellular fate.  Our staining technique utilizes an amphipathic dye that incorporates 
into cell membranes, thereby allowing us to follow the sporoplasm of the parasite, not 
the spore coat, which must be removed prior to replication. 
 Furthermore, proliferation in MDM was confirmed by BrdU incorporation as early 
as 72 hr PI, while ruptured and broken cells were observed at 168 hr PI (Fig. 2.4).  This 
indicates that these microsporidians are capable of completing their life cycle within 
MDM as early as 5 days post-infection and commit to successive rounds of re-invasion.  
Differences in kinetics between Encephalitozoon spp. were not detected and, therefore, 
demonstrate that both species have similar infection kinetics (Table 2.1).  Knowledge of 
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the kinetics of replication can be used to identify differences in host cell gene 
expression between initial, pre-proliferative events and those that occur during 
replication, as well as for studies of meront genomics.  This information could lead to a 
better understanding of what genes and proteins are being expressed or suppressed to 
produce a permissive environment and foster parasite development. 
 Treatment of macrophage with extracellular signals, such as IFN-γ and LPS, has 
been shown to prevent various intracellular pathogens from proliferating and to promote 
parasitic clearance.  These signals sensitize and activate the cells to release reactive 
oxygen and nitrogen species into membrane bound vesicles containing the parasite and 
promote fusion of degradative lysosomes (Janeway et al., 2005).  Our studies suggest 
that an extracellular signal must be present in order to reduce parasitic replication (Fig. 
2.5), as IFN-γ production was not detected upon spore exposure to resting MDM (data 
not shown).  Cultures pretreated with IFN-γ or LPS showed moderate decreases in 
parasitic replication, whereas, cultures treated with a combination of the 2 produced a 
significant decrease in MDM with replicating parasites; approximately a 44% decrease 
was observed.  Although a decrease in parasitic burden was observed, none of the 
treatments completely inhibited replication.  Similar results were reported by Didier and 
Shadduck (1994), when activating a murine macrophage cell line with either IFN-γ or 
LPS decreased the number of intracellular E. cuniculi spores over time in a dose-
dependent response.  Additionally, a combination of the 2 signals had an even greater 
decrease in the number of spores observed, but did not result in complete clearance of 
the spores (Didier and Shadduck, 1994).  In another study, SCID mice infected with E. 
cuniculi were reported to have 90% of their macrophages infected with spores by day 
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14, whereas spores were not observed in macrophages of wildtype mice (Salat et al., 
2001). Taken together, these reports indicate a necessity for a diverse immune 
response, possibly including CD8+ and γδ T cells (Khan et al., 1999; Moretto et al., 
2001), for a full recovery. 
 The intracellular fate of microsporidia has been the topic of debate in the 
literature (Franzen, 2004; Weidner, 1975).  Our studies clearly indicate that 
Encephalitozoon spp. can avoid destruction by naïve macrophages and replicate within 
these permissive cells resulting in the formation of mature spores.  We have recently 
reported that infected macrophage can induce a functional chemokine gradient leading 
to the recruitment of additional macrophages (Fischer et al., 2007), which correlate to 
the onset of parasitic replication.  Taken together, these studies suggest that 
microsporidia have a means of utilizing phagocytes responding to sites of infection as 
reservoirs for proliferation and as a media for the continuous growth and dissemination 
of the infection. 
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CHAPTER 3 
INDUCTION OF HOST CHEMOTACTIC RESPONSE BY ENCEPHALITOZOON SPP.∗ 
Introduction 
Microsporidiosis is a disease that is caused by an obligate intracellular, 
eukaryotic parasite and has gained recognition as an opportunistic infection in AIDS 
patients, commonly causing chronic diarrhea leading to malabsorption of nutrients and 
wasting (Kotler and Orenstein, 1994; Orenstein et al., 1990). The true extent of 
microsporidiosis is difficult to determine, because it is often under-reported due to a lack 
of proper facilities to diagnose this disease (Grant and De Cock, 2001).  Epidemiological 
reports indicate that anywhere from 5 to 50% (Khan et al., 2001) of patients with chronic 
diarrhea are positive for microsporidia, most notably Enterocytozoon bieneusi and 
Encephalitozoon spp. (Didier et al., 2004). Based upon the projections that in the course 
of HIV/AIDS about 93% of individuals have at least one bout of chronic diarrhea 
(Gazzard, 1988), these pathogens could conservatively account for chronic diarrhea in 
approximately 1.3 to 13.5 million people suffering from a life-threatening loss of 
nutrients and liquids in the Sub-Saharan region alone (The number of cases of 
microsporidiosis was estimated using previously published reports of the incidence [5 to 
50%] of infection in individuals who have chronic diarrhea and are HIV positive.  An 
estimated 93% of AIDS patients develop chronic diarrhea in regions, such as sub-
Saharan Africa, where water treatment and highly active antiretroviral therapy are 
                                                            
∗Reprinted from Infection and Immunity, Vol. 75(4), J. Fischer, J. West, N, Agochukwu, C. Suire, and H. 
Hale-Donze, Induction of Host Chemotactic Response by Encephalitozoon spp., Pages 1619-1652, 
Copyright 2007, with permission from American Society for Microbiology. 
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limited.  According to the 2005 UNAIDS/WHO AIDS report, 29 million individuals are 
infected with HIV in this region. 
More recently, cases of microsporidiosis in patients having received 
immunosuppressive therapies (Carlson et al., 2004; Goetz et al., 2001; Guerard et al., 
1999) or in immunocompetent individuals (Muller et al., 2001) having presented with 
symptoms of chronic diarrhea have been published.  Although the most common 
symptoms of the disease are enteric, there are accumulating reports of more severe 
disseminated disease, such as keratoconjunctivitis, sinusitis, tracheobronchitis, 
encephalitis, interstitial nephritis, hepatitis, cholecystitis, osteomyelitis, and myositis 
(Didier et al., 2004; Kotler and Heymsfield, 1998). 
Microsporidia are ubiquitous in nature and known to infect a variety of vertebrate 
and invertebrate organisms (Didier, 2005; Didier et al., 2000; Snowden et al., 1999; 
Visvesvara, 2002).  Once classified as protozoa, new evidence based on phylogenetic 
analysis suggests that these organisms are more closely related to fungi (Didier, 2005; 
Gill and Fast, 2006; Thomarat et al., 2004).  Of the more than 1200 species of 
microsporidia, only 14 have been reported to infect humans (Didier, 2005).  
Microsporidia infections are believed to occur when a spore is ingested from 
contaminated water or food (Didier, 2005).  Infections of epithelial and endothelial cells 
and macrophages are common (Khan et al., 2001).  Classically, cellular invasion occurs 
when a spore encounters a host cell and everts a polar tube, thereby penetrating the 
cell membrane of the host cell and injecting the sporoplasm.  Alternatively, spores can 
be internalized through phagocytosis or endocytosis (Franzen, 2004).  Further 
proliferation and spore production occur through merogony and sporogony within a 
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parasitophorous vacuole, followed by lysis of the host cell and release of mature spores 
(Franzen et al., 2005). 
While most studies of microsporidia have focused on their genome and life cycle 
(Didier et al., 2004), limited data exist concerning the host response to these 
opportunistic pathogens and especially their role in human macrophage infection and 
disseminated disease (Franzen, 2004; Orenstein, 2003).  Some reports indicate that 
macrophages/monocytes are the source of the disseminated pathogen (Orenstein et al., 
1997).  In individuals with multifocal organ involvement, infiltrates of infected 
macrophages are evident in lesions, microabscesses, and granulomas (Shadduck and 
Orenstein, 1993).  In animal models, injection of infectious spores results in a peritoneal 
infiltrate with predominately monocytes/macrophages, followed by disappearance of 
these cells, presumably spreading to the lymph nodes and into other tissues 
(Niederkorn et al., 1981; Salat et al., 2001).  Determining which chemokines are present 
is critical in the development of therapeutics that prevent the dissemination of the 
pathogen and consequent disease.  Based upon these reports, we have investigated 
the infections of two species of microsporidia that are known to cause disseminated 
diseases, Encephalitozoon cuniculi and Encephalitozoon intestinalis, and defined the 
subsequent production of a chemotactic gradient that is induced by an infection with 
these intracellular parasites.  This work provides the first description of the innate 
immune response in disseminating infections regarding chemokines and provides a 
foundation for describing the initial host reaction to these pathogens by human 
macrophages. 
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Materials and Methods 
Reagents and Antibodies.  Unless stated otherwise, all tissue culture media 
and plasticware were purchased from VWR (West Chester,PA), all neutralizing 
antibodies and protein array kits from R&D systems (Minneapolis, MN), all ELISA 
reagents from Biosource (Invitrogen, Carlsbad, CA), and all gene microarray materials 
from SuperArray Bioscience Corp (Frederick, MD).  
Cell Culture.  Peripheral blood mononuclear cells (MNC) were isolated from 
buffy coats from healthy donors (Our Lady of the Lake Regional Medical Center, Baton 
Rouge, LA) by gradient centrifugation on lymphocyte separation media (Cambrex).  
Monocyte-derived-macrophages (MDM) were obtained by adherence assays. Briefly, 
monocytes were plated into 75 cm2 flasks (1 x 107monocytes), 6-well culture plates 
containing coverglass, or 24-well (1 x 106monocytes/ml) culture dishes (Greiner Bio-
One, Cellstar)  for 3 hours in DMEM supplemented with 2 mM L-glutamine, 100 U/ml 
penicillin, 100 µg/ml streptomycin, 0.1 µg/ml gentamicin, and 0.25 µg/ml fungizone. 
Cells were stringently washed with PBS to remove non-adhered MNC and then allowed 
to differentiate for seven days in complete media with 10% FCS.    Monocytes used as 
target cells for recruitment in chemotaxis assays were isolated from mononuclear cells 
by magnetic bead separation using Dynal Monocyte Negative Isolation Kit (Invitrogen) 
and resuspended in complete media with 10% FCS.   
Microsporidians.  E. cuniculi III and E. intestinalis (a generous gift from 
Elizabeth Didier, Tulane National Primate Research Center, Covington, LA) were grown 
in a rabbit kidney cell line (ATCC CCL-37) and harvested from tissue culture 
supernatants.  Spores were washed once in PBS containing 0.2% Tween-20, 
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resuspended in supplemented DMEM, and counted with a hemacytometer (Didier et al., 
1991)  Some spores were inactivated by treatment with 10% bleach solution for 30 
minutes and washed 1x with water.  All spores were used at a 5:1 spore-to-MDM 
infection ratio (5X106 spores/ 1X106 macrophages), unless otherwise stated. 
Microscopy.  MDM, adhered to coverglass, were monitored for spore uptake by 
challenging them with either E. cuniculi or E. intestinalis spores labeled with PKH26 
Fluorescent Cell Linker, per manufacturer’s instructions, (Sigma, St. Louis, MO) for 
various times at 37 °C in 5% CO2.  Cells were fixed in 10% formalin (Sigma) and 
labeled with PKH67 Fluorescent Cell Linker (Sigma), general cell membrane label.  
Coverglasses were mounted in Prolong Gold antifade reagent with DAPI (Invitrogen) to 
detect nuclear staining of MDM.   
Microsporidia proliferation and infection were monitored using the 
Bromodeoxyuridine (BrdU) assay system (Invitrogen).  MDM were challenged with 
spores for 3 days and fixed with 4% paraformaldehyde.  24 hr prior to fixation, 100 µM 
of BrdU was added to each well.  Cells were washed with 1% Triton X-100 and treated 
with 1N HCl for 10 min. on ice, 2N HCl for 10 min. at RT, and 2N HCl for 20 min. at 37 
°C.  Cells were neutralized in a 0.1M borate buffer and washed with 1% Triton X-100.  
Coverslips were incubated on ice with a 1/50 dilution of anti-BrdU (Invitrogen) in 0.5% 
BSA and 1% Triton X-100 for 90 min.  Coverslips were washed with 1% Triton X-100 
and mounted in Prolong Gold antifade reagent (Invitrogen). 
Cells were viewed using a Leica DMI 6000 B inverted fluorescence microscope, 
and captured and analyzed with a Leica DFX300 FX CCD camera and Image Pro Plus 
v5.1 software (MediaCybernetics, Silver Spring, MD).   
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Chemotaxis Assay.  Co-culture chemotaxis assays were performed as 
previously described (Hale-Donze et al., 2002). Briefly, 7-day MDM were infected with 
E. cuniculi or E. intestinalis for 24 hr at 37 °C  in 5% CO2.  Sterile 3-µm polycarbonate 
transwell inserts (Corning Costar) were placed in 24-well plates that contained infected 
MDM.  Target monocytes were labeled with red fluorescent cell linker (Sigma) following 
manufacturer’s instructions and added to the top of the transwell inserts (1 x 106) and 
co-cultured with infected MDM for 24 hr at 37 °C in 5% CO2.  After co-culture, 
supernatants were removed and cells were fixed with 10% formalin.  In some of the 
cultures, supernatants were removed and collected after 24 hr infection and replaced 
with complete DMEM with 10% FCS containing one of the following neutralization 
antibodies: anti-CCL2 (0.9 µg/ml), -CCL3 (0.5 µg/ml), -CCL4 (0.3 µg/ml), or mouse 
IgG1/IgG2b (1.0 µg/ml). Migration of fluorescently labeled target cells was viewed and 
quantified using an inverted fluorescence microscope (Leica DMI 6000 B) and Image 
Pro Plus v5.1 software (Mediacybernetics).  Each experiment was completed in 
duplicate and ten fields of view were counted for each condition.  Ten donors were 
analyzed for infection with E. cuniculi and three donors with E. intestinalis.  Fold change 
in monocyte recruitment was calculated by dividing the number of cells migrating in the 
experimental condition by the number of cells in the untreated wells. 
Focused Microarray.  All focused microarray analyses were performed per 
manufacturer’s instructions (R&D systems).  Total RNA was isolated from 6 hr E. 
cuniculi infected MDM grown in 75 cm2 flasks using a  Qiagen RNeasy Mini Kit 
(Valencia, CA), quantified with a NanoDrop ND-1000 Spectrophotometer, and assessed 
for quality with an Experion Automated Electrophoresis System (Bio-Rad).  Total RNA 
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was amplified and labeled with Biotin-16-UTP (Roche Applied Science) using the 
TrueLabeling-AMP 2.0 Kit (SuperArray).  Amplified cRNA was, again, quantified and 
equally pooled in groups of three donors.  Pools of oligo cRNAs were hybridized to the 
Chemokines and Receptors Oligo GEArray (OHS-022) overnight in a hybridization oven 
at 60 °C.  Expressed genes were detected using a CDP-Star chemiluminescence kit 
(SuperArray) and imaged using the Bio-Rad Gel Doc 2000 system and Quantity One 
software (Bio-Rad).  Analysis of the data was performed using GEArray Expression 
Analysis Suite (SuperArray).  All data were normalized to the housekeeping genes 
GAPDH and β-actin, and background corrected to blank values.  Fold changes in gene 
expression are represented as the mean of two experiments. 
Focused Protein Array.  All focused protein arrays were performed per 
manufacturer’s instructions .  Supernatants from overnight infections with E. cuniculi 
were equally grouped in pools of six donors and incubated overnight to the Human 
Cytokine Array Panel A (R&D systems).  HRP substrate (Bio-Rad) was used to detect 
protein expression and captured by exposure to Kodak BioMax Light film.  Arrays were 
scanned into a computer and optical density measurements taken with Image Pro Plus 
v 5.1 software (Mediacybernetics).  Data is represented as the mean fold change of two 
experiments. 
ELISA. Supernatants were collected from MDM cultures at specified time 
intervals, post-infection with E. cuniculi or E. intestinalis, and analyzed for CCL2, CCL3, 
and CCL4 chemokine production by ELISA.  Samples were assayed in duplicate. 
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Statistical Analysis.  Student’s paired, two-tailed t test was used.  Values of p ≤ 
0.05 were considered significant.  All error bars shown in this paper are SEM.  Analyses 
were performed using InStat software (GraphPad). 
Results 
Infection of Primary Human Macrophages with Encephalitozoon spp. 
Recruits Monocytes in vitro.  To evaluate the host response generated to the initial 
spore entry, studies were conducted to determine the proper kinetics for obtaining 
cultures of primary macrophages in which the majority of cells contained visible 
vacuoles of microsporidia.  MDM grown on coverglass were challenged with labeled 
spores (red) and fixed in 10% buffered formalin at various times.  Host cells were 
labeled with a green membrane stain and a blue nuclear stain. Using fluorescence 
microscopy, cells positive for spores were counted in 10 consecutive fields.  In 
agreement with the kinetics previously reported (Franzen et al., 2005), it was 
established that more than 50% of cells contained peri-nuclear vacuoles of spores 
between 24 and 48 hr post-infection (Fig. 3.1A).  Distinct vacuoles containing labeled 
spores could be readily observed by 48 hr post-infection (Fig. 3.1B).  To determine if 
spore uptake resulted in microsporidia proliferation and productive infection, a BrdU 
assay system was performed.  Since MDM are terminally differentiated, only replicating 
meronts would incorporate the BrdU nucleotide.  At 72 hr post-infection, approximately 
27% of cells contained a peri-nuclear vacuole that stained positive for BrdU (Fig. 3.1C). 
To determine whether an infection of macrophages by Encephalitozoon spp. 
induces a recruitment of monocytes, a co-culture chemotaxis system, which was 
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Figure 3.1  Encephalitozoon spp. uptake and replication in macrophage.  MDM 
were challenged with labeled E. cuniculi spores (red) and the number of cells containing 
vacuoles of spores were counted in 10 fields over several time points (A). By 48 hr post-
challenge a majority of MDM are positive for parasitophorous vacuoles. (B) Arrows 
indicate the location of labeled spores contained in vacuoles that are peri-nuclear (blue) 
(n=3).  (C) By 72 hr post-infection, approximately 27% of MDM are positive for vacuoles 
containing replicating microsporidia as seen by the incorporation of BrdU (green) (n=3).  
Replication was not seen in MDM challenged with chlorine treated spores. 
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previously described (Hale-Donze et al., 2002), was used to detect a functional 
chemotactic gradient.  Initial experiments were conducted to determine the ratio of 
spores to MDM (2:1, 5:1, 10:1) needed to provide reproducible infection rates and 
immune responses.  An infection ratio of 5:1 gave consistent responses among all 
donors and was used as the infection ratio in all experiments presented (Fig. 3.2A).  
The fluorescent-labeled target cells in the transwell system allowed the times of optimal 
cell migration to be monitored.  MDM were infected for 24 hr prior to performing the 
analysis.  At the end of 24 hr, the supernatants containing any free spores were 
removed and new media were added.  Monocytes were labeled and placed into the 
upper chamber of a co-culture plate.  The cells were analyzed over the course of an 
additional 24 hr for prime chemotaxis response.  In initial experiments, the co-culture 
incubations were monitored at 30 minute intervals for up to 2 hr, and subsequently by 1 
hr increments up to 8 hr, and at 24 hr (data not shown).  The 24 hr incubation yielded 
the optimal response.  Infection of macrophages with either E. cuniculi or E. intestinalis 
induced a 2.9-fold increase in monocyte migration after a total of 48 hr post-infection 
(Fig. 3.2B).   To ensure that the observed monocyte migration was induced by a MDM-
generated gradient, only E. cuniculi spores were added to some wells.  Spores by 
themselves, do not induce migration (Fig. 3.2B). 
Focused Gene Array Reveals Upregulation of Chemokines and Receptors 
by E. cuniculi Infection.  To establish which chemokines and receptors may be 
responsible for initiating the monocytic infiltration, a limited, pathway-focused gene array 
for chemokine signaling was performed to screen for possible candidates.  Total RNA 
was isolated from MDM in medium alone or infected with E. cuniculi for 6 hr, converted 
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to biotinylated oligo cRNA and amplified.  The amplified cRNA was hybridized overnight 
and detected using a chemiluminescent substrate. 
 
Figure 3.2  Encephalitozoon spp. infection of human macrophages induce 
monocyte migration.  MDM were infected with E. cuniculi spores for 24 hr at a spore-
MDM ratio of 2:1, 5:1, and 10:1 to determine optimal spore infection ratios for monocyte 
recruitment (A). At 24 hr, labeled monocytes were added to transwell inserts and co-
cultured with infected MDM for an additional 24 hr.  A ratio of 5:1 spore-MDM resulted in 
consistent infection rates with human donors (A).  In co-culture chemotaxis assays, 
infection of MDM with either E. cuniculi or E. intestinalis resulted in a 2.9-fold 
recruitment of naïve monocytes (B). There were no significant differences in 
chemotactic response among Encephalitozoon spp.  Wells that contained only spores 
and no MDM did not induce a chemotactic response.  * p ≤ 0.05. 
 
Stimulation with E. cuniculi spores induced a 2-fold or greater increase in 40 out 
of 128 genes.  Included among the 40 genes that were augmented were several key 
chemokines and chemokine receptors, presented in Table 3.1.  E. cuniculi infection of 
MDM elicited expression of several important chemokines which are capable of 
recruiting the granulocytes [CXCL1, CXCL2, CXCL3, CXCL5, CXCL8], providing 
supporting evidence for other cell types present at sites of infection (Orenstein, 1999; 
Shadduck and Orenstein, 1993).  However, the vast majority of genes which were 
augmented by microsporidia infection were shown to recruit monocytes, including 
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CCL1, CCL2, CCL3, CCL4, CCL4L1, CCL5, and CCL7.  It is important to note that 
these chemokines can also act upon lymphocytes such as TH1 cells, and dendritic cells 
to influence their migration.  Additionally, increases in two vital monocyte receptors, 
CCR1 and CCR5, were also observed. 
 
Table 3.1  Microsporidia infection increases chemokine and receptor gene 
expression. 
 Gene 
name 
Common 
name 
Refseq no. Avg. Fold ∆a 
C-C Chemokines Ccl1 I-309 NM_002981 11.2 
 Ccl2 MCP-1 NM_002982 2.3 
 Ccl3 MIP-1α NM_002983 2.3 
 Ccl4 MIP-1β NM_002984 12.3 
 Ccl4l1 LAG-1 NM_207007 22.7 
 Ccl5 RANTES NM_002985 25.6 
 Ccl7 MCP-3 NM_006273 2.9 
 Ccl15 MIP-1δ NM_004167 8.4 
 Ccl20 MIP-3α NM_004591 6.2 
C-X-C Chemokines Cxcl1 GROα NM_001511 20.7 
 Cxcl2 GROβ NM_002089 21.4 
 Cxcl3 GROγ NM_002090 5.2 
 Cxcl5 ENA-78 NM_002994 5.7 
 Cxcl8 IL-8 NM_000584 9.9 
 Cxcl16  NM_022059 6.4 
C-C Receptors Ccr1  NM_001295 2.9 
 Ccr5  NM_000579 4.5 
 Ccr7  NM_001838 10.9 
 Ccr12  NM_003965 3.6 
C-X-C Receptors Cxcr4  NM_003467 2.2 
aAverage fold increases in MDM gene expression were determined at 6 hr post-
infection with E. cuniculi.  Each array experiment represents cRNA pooled from 
three donors (n=2). 
 
Proteomic Profiling Confirms Increased Levels of Chemokines After E. 
cuniculi Infection.  To verify the results obtained with the DNA arrays, a focused 
protein array, which includes several, but not all, of the chemokines of interest was 
performed.  Supernatants from MDM cultures infected for 6 hr with E. cuniculi were 
pooled in equal amounts from six donors and incubated overnight with the Human 
  72
Cytokine Array Panel A.  Detection using chemiluminescence showed significant 
increases (≥ 2-fold) in only a few of the proteins being screened for by the limited array 
(Table 3.2).  Both CCL3 and CCL4, monocyte chemoattractants, had greater than a 
15.0 fold increase, and CCL5, a potent chemokine for lymphocytes, had approximately 
a 25.0 fold increase  Moderate increases (≥ 1.5-fold) were seen in CCL1, CCL2, and 
CXCL1.  The modest difference seen in CXCL1 can be attributed to high levels in both 
the control and treated arrays, as was also true for the involvement of CXCL8. 
Table 3.2  Proteome Profiler Array 
 
Chemokine 
 
Common name 
Avg fold increase in 
expression 
  Protein arraya Gene arrayb 
CCL1 I-309 1.6 11.2 
CCL2 Monocyte chemoattractant protein 1 1.9 2.3 
CCL3 Macrophage inflammatory protein 1α 16.4 2.3 
CCL4 Macrophage inflammatory protein 1β 23.3 35.0e 
CCL5 RANTES 25.2 25.6 
CXCL1 Growth-regulated oncogene α 1.5 20.7 
CXCL8c Interleukin-8 1.1 9.9 
CXCL10c Interferon-inducible protein 10 0.9 1.0 
CXCL11d I-TAC 1.0 1.0 
CXCL12d Stromal cell-derived factor 1 1.0 1.0 
G-CSFd Colony-stimulating factor 3 1.0 6.9 
a Average fold change calculated by dividing the mean 
optical densities of infected MDM by uninfected MDM 
(n=2). 
b Average fold changes of gene expression from Table 
1. 
c Equivalent levels of protein was detected in both 
experimental conditions. 
d Protein was not detected in either condition. 
e Sum of the avg. fold increase of both CCL4 and CCL4L1 gene expression.  These two 
protein products are represented as MIP-1β on the protein array. 
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Sustained Chemotactic Levels Differ Between Encephalitozoon spp.  
Because microsporidia dissemination is thought to be associated with monocytic 
infiltrates, the data presented focuses on those chemokines that primarily recruit 
monocytes, namely CCL2, CCL3, and CCL4.  To establish the time at which these 
selected chemokines are elevated in Encephalitozoon infections, kinetic studies at 1, 3, 
6, 12, 24, 48 and 72 hr were conducted and protein levels measured by ELISA (Fig. 
3.3).  Significant differences in all three chemokine levels were detected at 6 hr post-
infection for both E. cuniculi and E. intestinalis.  Infections with E. cuniculi resulted in 
peak levels of CCL3 and CCL4 at 24 and 12 hr, respectively, followed by a decline.  
These levels appeared to undulate, but remained moderately high after their initial peak.  
CCL2 production continued to increase until 48 hr and then appeared to remain at this 
elevation.  Similarly, E. intestinalis resulted in peak levels of CCL3 and CCL4 at 24 hr, 
followed by a decrease.  The amount of CCL2 that was produced in response to E. 
intestinalis peaked by 12 hr and remained elevated up to 72 hr.  Levels of all 
chemokines produced were similar among the Encephalitozoon spp. through the 
kinetics of infection. 
Inhibiting CCL4 Significantly Reduces Cells Responding to 
Encephalitozoon Infection.  To evaluate whether any or all of the chemokines 
evaluated by ELISA contributed significantly to the infiltration of monocytes in the co-
culture system, MDM were infected for 24 hr with E. cuniculi or E. intestinalis.  The 
spent media were removed and fresh complete media containing antibodies against 
CCL2, CCL3, CCL4, a combination of the three antibodies, or isotype match control 
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were added prior to introducing the responding monocytes to the co-culture chemotaxis 
system. 
 
Figure 3.3  Levels of CCL2, CCL3, and CCL4 are elevated over time.  ELISA 
confirmed the results of the gene array and protein array for CCL2, CCL3, and CCL4.  
Supernatants were collected from co-cultures of MDM and E. cuniculi or E. intestinalis 
at multiple time points during infection.  Both Encephalitozoon spp. induce a strong 
chemotactic profile at approximately 24 hr of infection.  Thereafter, both CCL3 (n=6) and 
CCL4 (n=6) begin to decline in expression, whereas CCL2 (n=5) levels remain present 
after 24 hours.  * P<0.05. 
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In assays containing E. cuniculi, neutralizing antibodies against CCL2 or CCL3 
yielded a modest but significant decline in recruited monocytes by 25% and 31%, 
respectively. In contrast, the inhibition of CCL4 markedly decreased the number of 
migrating cells by 49% (Fig. 3.4A).  Similar results were obtained in cultures infected 
with E. intestinalis (Fig. 3.4B), in which, CCL2, CCL3, and CCL4 decreased migration 
by 28%, 36%, and 50%, respectively.  Furthermore, E. cuniculi cultures inhibited with 
combinations of two antibodies together resulted in a modest decrease with CCL2-
CCL3 (38%) or CCL2-CCL4 (45%) in infiltrating monocytes, while a CCL3-CCL4 
grouping further reduced recruitment by half.  Cultures containing a mixture of all three 
antibodies reduced the population of migrating cells by 58%. 
 
 
Figure 3.4  Neutralization of chemokines results in decreased monocyte 
recruitment.  Neutralizing CCL2 or CCL3 shows small but significant decreases in 
monocyte recruitment, whereas blocking CCL4 results in a more than 50% decline in 
monocytic infiltration.  Significant differences in cellular recruitment due to infection with 
either E. cuniculi (n=10) or E. intestinalis (n=3) were not observed.  * P<0.05. 
 
Discussion 
Limited data exist about the innate immune response against microsporidia.  
Increasingly, reports of microsporidian infections not only in immunocompromised but 
also in immunocompetent individuals are published, indicating the incidence of infection 
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may be more common than typically reported (Boldorini et al., 1998; Carlson et al., 
2004; Goetz et al., 2001; Guerard et al., 1999; Muller et al., 2001).  Histological studies 
of microsporidiosis show that infiltrates may often be composed of several cell types, 
including monocytes, granulocytes and lymphocytes (Boldorini et al., 1998; Didier, 
1998; Orenstein, 1991; Weber et al., 1994), however, infected macrophages have been 
observed in disseminated disease (Orenstein, 2003) and are thought to be the vehicle 
for multi-organ infections. 
The production of chemokines to recruit various immune cells during parasitic 
infections is important in innate immunity (Laing and Secombes, 2004).  Our data 
indicate that MDM infected with Encephalitozoon spp. induce a functional chemokine 
gradient that supports the recruitment of monocytes to sites of infection.  In these 
studies, E. cuniculi and E. intestinalis infected primary human macrophages induced an 
approximate three-fold increase in migration of naive monocytes after 24 hr incubation, 
in a chemotaxis system.  This delay in migration may reflect the parasitic evasion of the 
immune response providing time to invade and replicate (Fig. 3.1C). 
Focused microarray analyses of MDM infected with E. cuniculi revealed 
increases in expression of several critical chemokines and receptors needed to recruit a 
variety of effector cells in order to mount a successful immune response.  A case study, 
in a patient with AIDS, described an Encephalitozoon sp. infection of kidney epithelium 
that was surrounded by lymphocytes, plasma cells, and macrophages (Boldorini et al., 
1998), suggesting a role for these cells clearing infection. We show several genes 
involved in neutrophil recruitment, namely the C-X-C chemokines, that were strongly 
induced, as well as, genes involved in the chemotaxis of dendritic and TH1 cells, namely 
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CCL1 and CCL5 (Laing and Secombes, 2004).  In a murine model, Khan et al. reported 
that a TH1 response was critical against microsporidia infections (Khan and Moretto, 
1999), and later, further defined a role for CD8+ and γδ T cells in resolving these 
infections in mice (Khan et al., 2001; Khan et al., 1999).  CCL5 is a potent 
chemoattractant for memory T cells, IL-2 activated T cells and eosinophils (Laing and 
Secombes, 2004). Among the genes upregulated that are important in monocyte 
recruitment (Laing and Secombes, 2004), included CCL2, CCL3, CCL4 and CCL4L1.  
These four chemokines have been identified as agonists for the key monocyte receptors 
CCR1 and/or CCR5 (Murdoch and Finn, 2000), both of which showed increased 
expression in our model of infection.  This similar response has also been demonstrated 
in Candida albicans infection of human monocytes, where increased gene expression in 
CCL2, CCL3, and CCL4 chemokines, and CCR1 and CCR5 receptors has been 
observed (Kim et al., 2005).  Interestingly, as also seen in our model, C. albicans 
induces CCL4 expression many folds greater than either CCL2 or CCL3 at 6 hr post-
infection (Kim et al., 2005). 
To determine which of these genes give rise to protein products, a focused 
protein analysis was performed using proteome profiler arrays.  Data obtained from the 
limited array revealed that the chemokines CCL3, CCL4, and CCL5 had greater than a 
15-fold increase (Table 3.2).  Both, CCL3 and CCL4 are known to be strong inducers of 
monocytes to areas of infection and are also ligands for CCR5, a HIV co-receptor, 
whereas CCL5 predominately recruits T cells.  In addition, CCL2, which is another 
potent monocyte chemoattractant, displayed moderate, but significant levels of protein 
expression. 
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The secretion kinetics of monocyte chemokines most likely to participate in the 
spread of infection were further analyzed by ELISA to determine whether their 
expression coincide with the delayed recruitment observed.  Increased levels began 
around 6 hr and peaked between 12 and 24 hr.  These time points corresponded to the 
observed chemotactic response.  It has yet to be elucidated whether or not 
microsporidians can dampen immediate immune responses during host uptake until 
they have established the meront stage within the macrophage.  Delayed responses to 
other fungal pathogens including Aspergillus fumigatus, have been attributed to altered 
host response based upon the recognition of conidia verses hyphal forms or with 
Candida albicans yeast and hyphal forms which are thought to contribute to the 
pathology observed in these opportunistic infections (Roeder et al., 2004). 
To determine the individual role of these chemokines in the recruitment of 
potential new hosts for microsporidians, neutralizing antibodies were employed in the 
co-culture system.  This analysis revealed that CCL2 and CCL3 contributed to the 
migration of monocytes, but inhibiting CCL4 in the cultures resulted in the most dramatic 
reduction (Fig. 3.4).  The neutralization of all three major chemokines reduced the levels 
of migrating monocytes near that of uninfected MDM, suggesting that these three 
chemokines were the chemoattractants responsible for the monocytic infiltration and, 
therefore, could be potential targets of chemotherapeutic agents in controlling 
microsporidiosis (Pease and Williams, 2006).  In comparison, Huffnagle et al. showed in 
a murine model, that Cryptococcus neoformans, a yeast forming fungi known to cause 
disseminated disease, could envoke a MCP-1 and MIP-1α response.  In neutralization 
studies, the cryptococcal burden increased in the lungs of mice, while a decrease in 
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macrophage and CD4+ T cell recruitment was observed, resulting in inhibited clearance 
of the infection (Huffnagle et al., 1997; Huffnagle et al., 1995). 
While the immune response generated against Encephalitozoon spp. can result 
in the recruitment of monocytes, it also has the potential to mediate the adaptive 
immunity.  However, in individuals with impairment of  the adaptive arm of the immune 
system, as seen in AIDS, organ transplant recipients, the young and the very old, these 
same recruited monocytes could serve to amplify the infection.  Understanding how 
macrophages function in propagating disease and how the life cycle of microsporidia 
can influence their responses is critical in developing anti-microsporidial compounds or 
anti-inflammatory interventions.  Further works to define the host recognition of the 
parasite, signaling pathways and subsequent cytokine profiles are under current 
investigation. 
References 
Boldorini R., Monga G., Tosoni A., Didier E. S., Nebuloni M., Costanzi G., Mazzucco G. 
and Orenstein J. M. (1998) Renal Encephalitozoon (Septata) intestinalis infection 
in a patient with AIDS. Post-mortem identification by means of transmission 
electron microscopy and PCR. Virchows Arch 432, 535-9. 
Carlson J. R., Li L., Helton C. L., Munn R. J., Wasson K., Perez R. V., Gallay B. J. and 
Finkbeiner W. E. (2004) Disseminated microsporidiosis in a pancreas/kidney 
transplant recipient. Arch Pathol Lab Med 128, e41-3. 
Didier E. S. (1998) Microsporidiosis. Clin Infect Dis 27, 1-7. 
Didier E. S. (2005) Microsporidiosis: an emerging and opportunistic infection in humans 
and animals. Acta Trop 94, 61-76. 
Didier E. S., Didier P. J., Friedberg D. N., Stenson S. M., Orenstein J. M., Yee R. W., 
Tio F. O., Davis R. M., Vossbrinck C., Millichamp N. and et al. (1991) Isolation 
and characterization of a new human microsporidian, Encephalitozoon hellem (n. 
sp.), from three AIDS patients with keratoconjunctivitis. J Infect Dis 163, 617-21. 
Didier E. S., Didier P. J., Snowden K. F. and Shadduck J. A. (2000) Microsporidiosis in 
mammals. Microbes Infect 2, 709-20. 
  80
Didier E. S., Stovall M. E., Green L. C., Brindley P. J., Sestak K. and Didier P. J. (2004) 
Epidemiology of microsporidiosis: sources and modes of transmission. Vet 
Parasitol 126, 145-66. 
Franzen C. (2004) Microsporidia: how can they invade other cells? Trends Parasitol 20, 
275-9. 
Franzen C., Muller A., Hartmann P. and Salzberger B. (2005) Cell invasion and 
intracellular fate of Encephalitozoon cuniculi (Microsporidia). Parasitology 130, 
285-92. 
Gazzard B. G. (1988) HIV disease and the gastroenterologist. Gut 29, 1497-505. 
Gill E. E. and Fast N. M. (2006) Assessing the microsporidia-fungi relationship: 
Combined phylogenetic analysis of eight genes. Gene. 
Goetz M., Eichenlaub S., Pape G. R. and Hoffmann R. M. (2001) Chronic diarrhea as a 
result of intestinal microsposidiosis in a liver transplant recipient. Transplantation 
71, 334-7. 
Grant A. D. and De Cock K. M. (2001) ABC of AIDS. HIV infection and AIDS in the 
developing world. Bmj 322, 1475-8. 
Guerard A., Rabodonirina M., Cotte L., Liguory O., Piens M. A., Daoud S., Picot S. and 
Touraine J. L. (1999) Intestinal microsporidiosis occurring in two renal transplant 
recipients treated with mycophenolate mofetil. Transplantation 68, 699-707. 
Hale-Donze H., Greenwell-Wild T., Mizel D., Doherty T. M., Chatterjee D., Orenstein J. 
M. and Wahl S. M. (2002) Mycobacterium avium complex promotes recruitment 
of monocyte hosts for HIV-1 and bacteria. J Immunol 169, 3854-62. 
Huffnagle G. B., Strieter R. M., McNeil L. K., McDonald R. A., Burdick M. D., Kunkel S. 
L. and Toews G. B. (1997) Macrophage inflammatory protein-1alpha (MIP-
1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to 
a Cryptococcus neoformans infection. J Immunol 159, 318-27. 
Huffnagle G. B., Strieter R. M., Standiford T. J., McDonald R. A., Burdick M. D., Kunkel 
S. L. and Toews G. B. (1995) The role of monocyte chemotactic protein-1 (MCP-
1) in the recruitment of monocytes and CD4+ T cells during a pulmonary 
Cryptococcus neoformans infection. J Immunol 155, 4790-7. 
Khan I. A. and Moretto M. (1999) Role of gamma interferon in cellular immune response 
against murine Encephalitozoon cuniculi infection. Infect Immun 67, 1887-93. 
Khan I. A., Moretto M. and Weiss L. M. (2001) Immune response to Encephalitozoon 
cuniculi infection. Microbes Infect 3, 401-5. 
  81
Khan I. A., Schwartzman J. D., Kasper L. H. and Moretto M. (1999) CD8+ CTLs are 
essential for protective immunity against Encephalitozoon cuniculi infection. J 
Immunol 162, 6086-91. 
Kim H. S., Choi E. H., Khan J., Roilides E., Francesconi A., Kasai M., Sein T., 
Schaufele R. L., Sakurai K., Son C. G., Greer B. T., Chanock S., Lyman C. A. 
and Walsh T. J. (2005) Expression of genes encoding innate host defense 
molecules in normal human monocytes in response to Candida albicans. Infect 
Immun 73, 3714-24. 
Kotler D. and Heymsfield S. B. (1998) HIV infection: a model chronic illness for studying 
wasting diseases. Am J Clin Nutr 68, 519-20. 
Kotler D. P. and Orenstein J. M. (1994) Prevalence of intestinal microsporidiosis in HIV-
infected individuals referred for gastroenterological evaluation. Am J 
Gastroenterol 89, 1998-2002. 
Laing K. J. and Secombes C. J. (2004) Chemokines. Dev Comp Immunol 28, 443-60. 
Muller A., Bialek R., Kamper A., Fatkenheuer G., Salzberger B. and Franzen C. (2001) 
Detection of microsporidia in travelers with diarrhea. J Clin Microbiol 39, 1630-2. 
Murdoch C. and Finn A. (2000) Chemokine receptors and their role in inflammation and 
infectious diseases. Blood 95, 3032-43. 
Niederkorn J. Y., Shadduck J. A. and Schmidt E. C. (1981) Susceptibility of selected 
inbred strains of mice to Encephalitozoon cuniculi. J Infect Dis 144, 249-53. 
Orenstein D. P. K. a. J. M. (1999) Clinical Syndromes Associated With Microsporidiosis. 
In The Microsporidia and Microsporidiosis (Edited by Weiss M. W. a. L. M.), p. 
258-92. ASM Press, Washington, DC. 
Orenstein J. M. (1991) Microsporidiosis in the acquired immunodeficiency syndrome. J 
Parasitol 77, 843-64. 
Orenstein J. M. (2003) Diagnostic pathology of microsporidiosis. Ultrastruct Pathol 27, 
141-9. 
Orenstein J. M., Chiang J., Steinberg W., Smith P. D., Rotterdam H. and Kotler D. P. 
(1990) Intestinal microsporidiosis as a cause of diarrhea in human 
immunodeficiency virus-infected patients: a report of 20 cases. Hum Pathol 21, 
475-81. 
Orenstein J. M., Gaetz H. P., Yachnis A. T., Frankel S. S., Mertens R. B. and Didier E. 
S. (1997) Disseminated microsporidiosis in AIDS: are any organs spared? Aids 
11, 385-6. 
  82
Pease J. E. and Williams T. J. (2006) The attraction of chemokines as a target for 
specific anti-inflammatory therapy. Br J Pharmacol 147 Suppl 1, S212-21. 
Roeder A., Kirschning C. J., Rupec R. A., Schaller M. and Korting H. C. (2004) Toll-like 
receptors and innate antifungal responses. Trends Microbiol 12, 44-9. 
Salat J., Braunfuchsova P. and Kopecky J. (2001) Experimental infection of 
immunocompetent and immunodeficient mice with Encephalitozoon cuniculi. 
Folia Parasitol (Praha) 48, 249-54. 
Shadduck J. A. and Orenstein J. M. (1993) Comparative pathology of microsporidiosis. 
Arch Pathol Lab Med 117, 1215-9. 
Snowden K., Logan K. and Didier E. S. (1999) Encephalitozoon cuniculi strain III is a 
cause of encephalitozoonosis in both humans and dogs. J Infect Dis 180, 2086-
8. 
Thomarat F., Vivares C. P. and Gouy M. (2004) Phylogenetic analysis of the complete 
genome sequence of Encephalitozoon cuniculi supports the fungal origin of 
microsporidia and reveals a high frequency of fast-evolving genes. J Mol Evol 59, 
780-91. 
Visvesvara G. S. (2002) In vitro cultivation of microsporidia of clinical importance. Clin 
Microbiol Rev 15, 401-13. 
Weber R., Bryan R. T., Schwartz D. A. and Owen R. L. (1994) Human microsporidial 
infections. Clin Microbiol Rev 7, 426-61. 
 
 
 
 
 
 
 
 
 
 
 
  83
CHAPTER 4 
TLR2 RECOGNITION OF THE MICROSPORIDIA ENCEPHALITOZOON SPP. 
INDUCES NUCLEAR TRANSLOCATION OF NF-κB AND SUBSEQUENT 
INFLAMMATORY RESPONSES 
 
Introduction 
Microsporidiosis has been reported as the cause of chronic and life-threatening 
diseases in HIV/AIDS patients and organ recipients, and therefore, grained a greater 
medical importance amongst individuals who have an impaired immune status (Didier, 
2005; Orenstein, 2003; Schottelius and da Costa, 2000).  Increasingly, infections 
involving immunocompetent individuals, particularly affecting the elderly or young, have 
also been reported (Carlson et al., 2004; Didier, 2005; Didier et al., 2004; Leelayoova et 
al., 2005; Nkinin et al., 2007).  Infections are believed to primarily occur through the 
ingestion of  microsporidia spores and proceed through the invasion of enterocytes in 
the small intestine (Didier, 2005).  Clinical reports of microsporidiosis have described a 
range in severity of the disease, consisting of intestinal infections leading to chronic 
diarrhea and disseminated diseases thought to occur as a result of migrating 
macrophages, including keratoconjunctivitis, sinusitis, tracheobronchitis, encephalitis, 
interstitial nephritis, hepatitis, cholecystitis, osteomyelitis, and myositis (Didier, 2005; 
Hale-Donze and Didier, 2007; Orenstein, 2003; Schottelius and da Costa, 2000). 
Microsporidia comprise a group of more than 1200 species of obligate 
intracellular pathogens that can be found virtually everywhere in nature and are able to 
infect a wide variety of vertebrate and invertebrate organisms (Bigliardi and Sacchi, 
2001; Didier, 2005; Franzen, 2005; Gill and Fast, 2006). These parasites were once 
classified as protozoa, however, recent phylogenetic analysis has revealed their close 
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association with fungi (Didier, 2005; Gill and Fast, 2006).  The infective stage of the 
parasite is an environmentally resistant spore that is believed to infect cells through the 
eversion of a unique polar filament, which structurally distinguishes microsporidia from 
other spore-forming organisms (Bigliardi and Sacchi, 2001; Didier, 2005; Franzen, 
2005).  The polar filament functions similar to a syringe and needle by penetrating the 
host membrane and forcing the sporoplasm through the tube and into the host cell 
(Bigliardi and Sacchi, 2001; Didier, 2005; Franzen, 2005; Xu and Weiss, 2005).  For 
macrophages, infection has been reported to occur via phagocytosis of the infectious 
spore (Fischer et al., 2008).  However, the specific mechanism of macrophage 
recognition of these spores has not been reported. 
 Host recognition of pathogens is accomplished by a diverse repertoire of germ-
line encoded proteins called pattern recognition receptors (PRR).  Toll-like receptors 
(TLR) represent a unique collection of evolutionarily conserved PRR known to 
recognize pathogen-associated molecular patterns (PAMPs) found on viruses, bacteria, 
parasites, and fungi.  Ten TLR have been identified in humans and are known to 
recognize molecular moieties, such as peptidoglycan and zymosan by TLR2 or 
lipopolysaccharide by TLR4 (Lee and Kim, 2007; Takeda and Akira, 2005).  
Engagement of TLR has been shown to activate a variety of intracellular signaling 
pathways, including the MyD88-dependent pathway which ultimately activates the 
transcriptional factor NF-κB (Lee and Kim, 2007; Medzhitov, 2001; Takeda and Akira, 
2005).  Activation and nuclear translocation of NF-κB is implemented in the transcription 
of many inflammatory cytokines and chemokines needed for successful clearance of the 
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pathogen and recruitment of immune cells, including TNF-α and IL-8 (Collart et al., 
1990; Kunsch and Rosen, 1993).   
Since the discovery of TLR, their recognition of molecular patterns on bacteria 
and viruses has been well documented.  More recently a number of protozoan and 
fungal organisms that share structural and/or biological similarities with microsporidia 
have also been linked with TLR activation.  Cryptosporidium parvum, an oocyst-forming 
protozoan that typically infects the small intestine, recruits both TLR2 and TLR4 and 
activates NF-κB signaling in human cholangiocytes (Chen et al., 2005).  Genomic 
analysis of Encephalitozoon spp. has predicted that the spore coats may contain 
glycosylphosphatidylinositol (GPI)-anchors (Peuvel-Fanget et al., 2006; Xu et al., 2006) 
which recently have also been considered key molecules isolated from Toxoplasma 
gondi and Trypanosoma cruzi and shown to signal through TLR2 and TLR4 (Campos et 
al., 2001; Debierre-Grockiego et al., 2007).   Additionally, TLR have been shown to 
recognize highly conserved fungal cell wall components such as glucans, chitin, and 
mannoproteins from Candida and Aspergillus organisms, which share some similarities 
to recently identified microsporidian spore coat molecules (Netea et al., 2006a; Netea et 
al., 2006b). 
To date, there is limited information about the host innate immune response to 
microsporidia and no information exists about the role of TLR in the recognition of these 
parasites.  However, studies involving microsporidian infection have provided some 
evidence that suggests an involvement of NF-κB.  Analyses of culture supernatants 
from primary human macrophages challenged with Encephalitozoon spp. spores 
revealed increases in the levels of the cytokine TNF-α (Franzen et al., 2005) and the 
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chemokines CCL2, CCL3, and CCL4 in response to infection (Fischer et al., 2007).    
Taken together, these reports of inflammatory mediator production and the previously 
described biological similarities between microsporidia and pathogens that are known to 
activate TLR, suggest that microsporidia may also be recognized by and elicit a TLR 
response. 
The present study has explored the role of TLR in macrophage host defense 
against microsporidian parasites.  We report that Encephalitozoon cuniculi and 
Encephalitozoon intestinalis are both recognized by TLR2.  In addition, parasite 
challenge leads to the nuclear translocation of NF-κB, which is required for TNF-α and 
IL-8 production.  To our knowledge, this is the first study that demonstrates a role for 
TLR in the innate immune response to any species of microsporidia. 
Materials and Methods 
Reagents.  Lymphocyte separation media (LSM), fetal calf serum (FCS), L-
glutamine, gentamicin, penicillin, and streptomycin were purchased from Cambrex 
(Walkersville, Maryland), and Dulbecco’s modified Eagle’s medium (DMEM), 
phosphate-buffered saline (PBS), and Greiner Bio-One, Cellstar tissue culture plates 
were from VWR International (West Chester, Pennsylvania).  Lipopolysaccharide (LPS) 
from E. coli 0111:B4 was from Sigma Chemical Co. (St. Louis, Missouri) and Pam3CSK4 
was from Axxora (San Diego, California).  ELISA reagents and antibodies, goat anti-
rabbit Alexa Fluor 488, and Lipofectamine 2000 were purchased from Invitrogen 
(Carlsbad, California) and anti-NF-κBp65 was from Santa Cruz Biotechnology, Inc., 
(Santa Cruz, California).  NF-κB inhibitor (Bay11-7085), all validated RT-qPCR primers, 
and RT2 SYBR Green/Fluorescein master mix were from SuperArray (Frederick, 
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Maryland). Predesigned TLR2 and control oligonucleotides were purchased from 
Ambion (Foster City, California). 
 Cell Culture.  Peripheral blood mononuclear cells (PBMC) were isolated from 
buffy coats of healthy donors (Our Lady of the Lake Regional Blood Bank, Baton 
Rouge, Louisiana) by gradient centrifugation on lymphocyte separation media.  
Monocyte-derived-macrophages (MDM) were obtained by adherence assays, as 
previously reported (Fischer et al., 2007). Briefly, monocytes were plated onto 6-well (2 
x 106 cells/well), 24-well (5 x 105 cells/well), and 96-well (1 x 105 cells/well) culture 
plates and cultured for 3 hr in supplemented DMEM containing 2 mM L-glutamine, 100 
U/ml penicillin, 100 µg/ml streptomycin, and 0.1 µg/ml gentamicin at 37 °C in 5% CO2. 
Cells were stringently washed with PBS to remove non-adhered PBMC and then 
allowed to differentiate for 7 days in supplemented DMEM with 10% FCS at 37 °C in 5% 
CO2.  Some MDM were plated in 24-well culture plates with coverglasses. 
 Parasites.  Encephalitozoon cuniculi III and E. intestinalis (a generous gift from 
Elizabeth Didier, Tulane National Primate Research Center, Covington, LA) were grown 
in a rabbit kidney cell line (ATCC CCL-37) in DMEM supplemented with 10% FCS at 37 
°C in 5% CO2, and harvested from tissue culture supernatants.  Spores were washed 
once in PBS containing 0.2% Tween-20, resuspended in supplemented DMEM, and 
counted with a hemacytometer (Didier et al., 1991).  Spores were used at a 5:1 spore-
to-MDM ratio (Fischer et al., 2007).  Some spores were heat-inactivated in a 95 °C 
water bath for 30 min. 
 TLR Transfected HEK Cell Lines.  HEK cell lines transfected with TLR2, TLR4, 
TLR4/MD2/CD14, or Null plasmids (Invivogen, San Diego, California) were grown in 96 
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well culture plates in supplemented DMEM with 10% FCS at 37 °C in 5% CO2.  
Confluent cultures were challenged with spores of E. cuniculi or E. intestinalis and 
supernatants were collected and analyzed by ELISA for TLR activation via IL-8 
production as suggested by the manufacturer.  As controls, some cultures were 
stimulated with the TLR4 or TLR2 agonists LPS (10 ng/ml) or Pam3CSK4 (50 ng/ml), 
respectively. 
 Real-time Quantitative PCR (RT-qPCR).  Total RNA was isolated from 1 x 107 
E. cuniculi or E. intestinalis infected MDM grown in 6 well culture plates using the 
Qiagen RNeasy Mini Kit (Valencia, California) according to the manufacturer’s 
instructions, quantified with a NanoDrop ND-1000 Spectrophotometer (Wilmington, 
Delaware), and assessed for quality with an Experion Automated Electrophoresis 
System (Bio-Rad, Hercules, California).  Reverse transcription was performed with 
SuperScript III First Strand Synthesis Supermix (Invitrogen).  RT-qPCR was performed 
using a BioRad iCycler according to the manufacturer’s instructions.  The amplification 
of TNF-α, TLR2, and TLR4 cDNA was completed using validated primers and RT2 
SYBR Green/Fluorescein master mix.  All data were normalized to the β-actin 
housekeeping gene and gene expression was calculated as previously described 
(Khaleduzzaman et al., 2007).  Briefly, the cycle threshold (CT) value (log2) for β-actin 
minus the CT value of the gene of interest for each sample (∆CΤ = CT β-actin – CT gene 
of interest) were calculated and presented as the percentage of β-actin. 
 Immunofluorescence Detection of Nuclear NF-κB.  Adherent cells on 
coverglasses were challenged with spores or LPS (10 ng/ml)  for 1 or 6 hr, fixed with 
4% paraformaldehyde and permeabilized with 0.1% Triton X-100 in PBS.  Cells were 
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then incubated with Image FX Signal Enhancer (Invitrogen) for 30 min at RT followed by 
polyclonal rabbit anti-mouse NFκBp65 (1:50 dilution) overnight at 4 °C.  The cells were 
extensively washed in PBS and then incubated with goat anti-rabbit Alexa Fluor 488 
(1:200 dilution) for 60 min at RT, washed again, and mounted in ProLong Gold media 
(Invitrogen).  Cells were examined using a Leica DMI 6000 B inverted fluorescence 
microscope, and captured and analyzed with a Leica DFX300 FX CCD camera and 
Image Pro Plus v5.1 software (MediaCybernetics, Silver Spring, Maryland). 
 ELISA.  Supernatants were collected from MDM cultures at specified time 
intervals, post-infection with E. cuniculi or E. intestinalis, and analyzed for TNF-α, IL-8, 
CCL3, and CCL4 cytokine/chemokine production as per manufacturer’s instruction. 
Nuclear extracts were collected and assayed for the translocation of NF-κB following 
the manufacturer’s protocol.  Samples were assayed in duplicate. In some experiments, 
20 µm of the NF-κB inhibitor, Bay11-7085, was added to cell cultures  1 hr prior to 
infection.  Colormetric determination of values was performed on VersaMax microplate 
reader (Molecular Devices, Sunnyvale, California) and analyzed using SoftMax Pro 
software (Molecular Devices). 
 siRNA.  Three TLR2 siRNA sequences were equally mixed in each transfection 
and experiments were performed as previously described (Wang et al., 2005).  Briefly, 
MDM were seeded in 96-well plates at 1 x 105 cells per well in serum-free, 
supplemented DMEM.  MDM were transfected with 20 pmol of siRNA and 1 µl of 
Lipofectamine 2000 per well.  Cultures were allowed to incubate with siRNA-
Lipofectamine complexes for 4 hr at 37 °C in 5% CO2, washed, and placed in fresh 
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supplemented DMEM with 10% FCS for 48 hr prior to performing experiments.  siRNA 
knockdown of the specific gene was confirmed by RT-qPCR.  
 Statistical Analysis.  Three experiments were performed at each time point and 
for each parasite or condition, unless otherwise stated.  Each experiment consisted of a 
single donor and was measured in duplicate.  Statistical significance was determined by 
one-way ANOVA followed by Dunnett’s post test, and values of p ≤ 0.05 were 
considered significant.  All error bars shown in this paper are SEM.  Analyses were 
performed using InStat software (GraphPad 3.0, San Diego, California). 
Results 
TLR2 Mediates the Recognition of Encephalitozoon spp.  To delineate a role 
for TLRs in the recognition of microsporidian parasites, HEK293 cells stably transfected 
with plasmids containing null, TLR2, TLR4, or the complex TLR4/MD2/CD14 (confirmed 
in LPS recognition and signaling), were stimulated with spores from two 
Encephalitozoon spp.  HEK293 cells do not express TLR, but do contain the 
intracellular machinery to provide a response if the receptor was available.  When 
stimulated, these transfected cells provide an IL-8 response (Raffatellu et al., 2005).  
The HEK293-null cell line did not respond to either Encephalitozoon spp., or TLR 
agonist (Fig. 4.1A) indicating that no native IL-8 responses were generated against the 
spores. Detection of IL-8 was observed in TLR2 transfected cells challenged with 
spores from both species and heat-killed E. cuniculi spores (Fig. 4.1B).   Neither TLR4 
alone (Fig. 4.1C) nor the TLR4/MD2/CD14 (Fig. 4.1D) complex generated a signal in 
response to the challenge with Encephalitozoon spores.  As well, heat-killed spores did 
not generate a strong signal.  These data suggests that spores of the Encephalitozoon 
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spp. are recognized by TLR2 which could initiate subsequent inflammatory signaling 
and production of mediators. 
 
Figure 4.1.  Encephalitozoon spp. are recognized by TLR2.  HEK293 cells transfected 
with plasmids encoding Null (A), TLR2 (B), TLR4 (C), or TLR4/MD2/CD14 (D) were 
challenged with spores of Encephalitozoon spp., heat-inactivated (∆) E. cuniculi, LPS 
(10ng/ml), or Pam3CSK4 (50ng/ml) overnight.  Culture supernatants were collected and 
assessed for IL-8 production by ELISA (n=3).  *, p ≤ 0.05. 
 
Encephalitozoon Stimulation Increased TLR2 Expression in Human Primary 
Macrophages.  While HEK293 cell lines are widely used to determine TLR responses 
to pathogens, it is important to establish the role of these receptors in cells which are 
involved in recognition of Encephalitozoons in vivo.  Macrophages are not only involved 
in innate immune responses against microsporidia, but can also serve as vessels for the 
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dissemination of infection in the immunocompromised host, therefore primary human 
macrophages were analyzed for altered gene expression of TLR in response to 
Encephalitozoon spp.  MDM were incubated with spores for 6 hr and total RNA was 
collected.  Gene expression of TLR2, TLR4, and TNF-α (a known product of parasite 
challenge) was assessed using RT-qPCR.  While the parasite challenge caused the 
predicted increase in TNF-α expression (Fig. 4.2A), an approximate 2-fold increase in 
TLR2 mRNA levels was also observed (Fig. 4.2B).  Similar induction of TLR2 was 
observed for both E. cuniculi and E. intestinalis. Interestingly, TLR4 gene expression 
was not significantly augmented (Fig. 4.2C).  These results along with the TLR2 
transfection studies, strongly suggest that the infectious spores can induce responses to 
increase the host receptor required for their recognition. 
 NF-κB Translocation Is Activated in Macrophages Challenged with Spores.  
Little is understood about signaling events in response to microsporidian infections.  
Since many pro-inflammatory cytokines are at least under partial regulation of the 
transcription activator NF-κB, our HEK studies and previously published reports of TNF-
α would suggest that NF-κB is activated during these infections.  We next investigated 
whether Encephalitozoon spores could induce the translocation of NF-κBp65 into the 
nuclear compartment of primary human macrophages.  Nuclear extracts were collected 
from cells at 1, 3, and 6 hr post-challenge with spores, and measured for total NF-
κBp65.  Translocation of NF-κBp65 was detected as early as 1 hr post-challenge and 
continued to decrease at 3 and 6 hr (Fig. 4.3A).  To confirm the nuclear localization of 
NF-κBp65 in macrophages, immunostaining was performed on cells after challenge with 
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spores from both species.  Again, NF-κBp65 was observed in the nucleus optimally at 1 
hr (Fig. 4.3B) and continued to decline out to 6 hr. 
 
Figure 4.2.  Microsporidia induce increased gene expression of TLR2, but not TLR4, in 
primary human macrophages.  Total RNA was extracted from MDM cultures after 
challenge with spores for 6 hr and gene expression of TLR2, TLR4, and TNF-α was 
measured by RT-qPCR.  Data represented as the means of 6 (TLR2, TLR4) and 3 
(TNF-α) experiments.  *, p ≤ 0.05. 
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Figure 4.3.  Nuclear translocation of NF-κBp65 in primary human macrophages is 
initiated early after challenge with spores of Encephalitozoon spp.  MDM cultures in 6-
well plates were challenged with spores for 1, 3, or 6 hr.  Nuclear proteins were 
collected and analyzed for levels of NF-κBp65 subunit by ELISA.  (A) Significant levels 
were observed at both 1 and 3 hr post-challenge, while levels returned back to that of 
control by 6 hr (n=4).  To confirm NF-κBp65 activity, some MDM cultures were plated on 
coverglass and immunostained for nuclear localization.  Nuclear NF-κB (green) was 
clearly observed at 1 hr (B) in the nucleus, but not 6 hr post-challenge.  *,p ≤ 0.05. 
 
Encephalitozoon spp. Induce the Production of Pro-inflammatory 
Cytokines in Primary Human Macrophages.  To substantiate the role of macrophage 
in recognition of Encephalitozoons in inducing inflammatory responses, the temporal 
expression of two inflammatory mediators, TNF-α and IL-8, was established.  TNF-α 
and IL-8 are key inflammatory cytokines/chemokines that are produced in response to 
numerous types of intracellular pathogens.  TNF-α and IL-8 were measured in 
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supernatants from MDM cultures challenged with spores at various time points.  Both 
species of microsporidia induced a strong, significant TNF-α response by 3 hr post-
challenge, which peaked at 12 hr and sharply fell after 24 hr (Fig. 4.4A).  In contrast, the 
production of IL-8 increased significantly by 6 hr post-challenge and continued to 
increase overtime out to 72 hr (Fig. 4.4B).  
 
Figure 4.4.  Microsporidia induce the production of TNF-α and IL-8 by primary human 
macrophages.  MDM cultures in 96-well plates were challenged with spores and 
stopped at various times by collecting the supernatants.  TNF-α (A) and IL-8 (B) levels 
in supernatants were determined by ELISA.  Data represented as the means of 6 (TNF-
α) and 3 (IL-8)   experiments.  At time points 3, 6, 12, 24 hr for TNF-α and 6, 12, 24, 48, 
72 hr for IL-8, p ≤ 0.05. 
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Encephalitozoon Induced NF-κB Translocation in Macrophages Is Required 
for the Production of TNF-α and IL-8.  To establish the role of NF-κB in the production 
of the inflammatory mediators TNF-α and IL-8 in response to Encephalitozoon spores, 
the NF-κB inhibitor, Bay11-7085, was added to MDM cultures for 1 hr prior to challenge 
with microsporidia spores.  This inhibitor is known to prevent the phosphorylation and 
degradation of IκB, thus, preventing the nuclear translocation of NF-κB (Pierce et al., 
1997).  A significant reduction in both TNF-α and IL-8 levels at 12 hr was observed in 
cultures treated with Bay11-7085 (Fig. 4.5A-D).  As anticipated, NF-κB activation is 
required for producing an effective inflammatory response against the parasites. 
 
Figure 4.5.  Blocking NF-κB activity prevents the production of microsporidia induced 
TNF-α and IL-8 from primary human macrophages challenged with spores.  Cultures of 
MDM in 96-well plates were pre-incubated for 60 min. with 20 µm of the NF-κB inhibitor, 
Bay11-7085, followed by a 12 hr challenge with Encephalitozoon spores or LPS 
(10ng/ml).  Levels of TNF-α and IL-8 were measured by ELISA.  TNF-α (A-B) and IL-8 
(C-D) were abrogated in cultures of both MDM in comparison to cultures without the 
addition of inhibitor (n=3).  *, p ≤ 0.05. 
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TLR2 Knockdown in Macrophages Inhibits NF-κB Nuclear Translocation 
and Subsequent Cytokine and Chemokine Responses Against Microsporidia.  To 
directly show that the engagement of TLR2 by Encephalitozoon spp. in primary human 
macrophages results in NF-κB translocation, and the production of inflammatory 
mediators, MDM were transfected with either control or TLR2 siRNA.  Treatment with 
siRNA inhibits TLR2 mRNA expression, which could not be detected by RT-qPCR.  
TLR2 siRNA altered NF-κBp65 translocation, which was observed in control cells at 1 hr 
challenge with E. cuniculi, but not in TLR2 siRNA treated cells (Fig 4.6A).  After a 12 hr 
challenge with the parasites, cell culture supernatants were collected and measured for 
levels of TNF-α and IL-8 mediators, as well as, two NF-κB driven chemokines, CCL3 
and CCL4, previously described as being produced in response to Encephalitozoon 
challenge (Fischer et al., 2007).  The knockdown of TLR2 resulted in an approximate 2-
fold decline in the production of TNF-α (Fig. 4.6B) and IL-8 (Fig. 4.6C) in comparison to 
control siRNA transfected MDM when challenged with either species of parasite.  A 
reduction was also observed in siRNA TLR2 transfected MDM stimulated with the TLR2 
agonist, Pam3CSK4, whereas the siRNA knockdown had no effect on the cytokine 
response to the TLR4 agonist LPS.  Similar results were also observed in supernatants 
analyzed for levels of CCL3 (Fig. 4.6D) and CCL4 (Fig. 4.6E).  Levels of both 
chemokines were decreased in TLR2 transfected MDM as compared to control 
transfects.   Taken together, these data show a direct reduction in these four 
inflammatory mediators as a result of Encephalitozoon spp. ligation of TLR2 and 
subsequent NF-κB activation in primary human macrophages. 
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Figure 4.6.  siRNA gene silencing of TLR2 reduced Encephalitozoon-mediated NF-κB 
nuclear translocation and inflammatory responses.  MDM transfected with TLR2 siRNA 
were challenged with Encephalitozoon spores, LPS (10ng/ml), or Pam3CSK4 (50ng/ml) 
for 12 hr.  Cells on coverslips were analyzed by immunofluorescence microscopy for 
nuclear NF-κB (A) and culture supernatants analyzed by ELISA for the production of 
TNF-α (B), IL-8 (C), CCL3 (D), and CCL4 (E) inflammatory mediators.  For 
Encephalitozoon challenge, data represented as the means of 9 (TNF-α; IL-8) and 5 
(CCL3; CCL4) experiments.  *, p ≤ 0.05. 
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Discussion 
Encephalitozoon spp. have been recognized as emerging pathogens, however 
very little knowledge about the immunobiology of microsporidiosis in humans is 
available.  Pathology and epidemiological reports have identified immune effector cells 
at sites of infection (Orenstein, 2003) and detected increased levels of serum antibodies 
for microsporidia in humans (Halanova et al., 2003; van Gool et al., 2004).  Recent in 
vitro studies have shown that infections lead to the production of numerous cytokines 
and chemokines including TNF-α, CCL2, CCL3, and CCL4 (Fischer et al., 2007; 
Franzen et al., 2005).  Although these responses have been well-documented, to date 
no known receptor involved in microsporidia recognition and signaling has been 
identified. 
TLR have been shown to mediate the responses of many host-pathogen 
interactions.  This family of receptors was first identified in Drosophila Toll-mutants that 
succumbed to fungal infections and soon after their receptor homologues were 
identified in mammals (Lemaitre et al., 1996; Medzhitov, 2001; Rock et al., 1998; 
Takeda and Akira, 2005). Many insects, including Drosophila, are natural host for 
entomogenous microsporidia (Becnel and Andreadis, 1999).  Given these receptors’ 
involvement in inducing innate immune mechanisms leading to inflammatory responses, 
such as those previously reported against microsporidia, and their presence in all major 
natural hosts for microsporidia, toll-like receptors were investigated for their role in host 
recognition of Encephalitozoon spp. We report here, that Encephalitozoon cuniculi and 
Encephalitozoon intestinalis are recognized by TLR2.  Furthermore, the TLR2-parasite 
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interaction mediates the nuclear translocation of NF-κB, which initiates the production of 
inflammatory mediators, such as TNF-α, IL-8, CCL3, and CCL4. 
 Although the cytokine and chemokine responses to Encephalitozoon infection 
have been described in previous studies, intracellular signaling molecules involved in 
the induction of this cascade, such as NF-κB, have not been reported.  Similar to the 
reports of others (Franzen et al., 2005), we found that both species of Encephalitozoon 
elicit a very strong inflammatory response when introduced to primary human 
macrophages, and here we show that this interaction results in a rapid nuclear 
translocation of NF-κB (Fig. 4.3) and robust TNF-α and IL-8 production (Fig. 4.4) that 
can be inhibited by blocking IκB phosphorylation (Fig. 4.5).  Interestingly, our temporal 
studies reveal that NF-κB translocation begins as early as 1 hr post-challenge, but 
continuously decreases thereafter and returns to levels of that of control by 6 hr (Fig. 
4.3).  The decrease in nuclear NF-κB is reflected in our TNF-α data which shows 
increases in secreted protein levels to 12 hr, followed by a sharp decrease at 24 hr (Fig. 
4.4).  Increases in TNF-α mRNA at 6 hr post-challenge (Fig. 4.2) followed by declining 
levels overtime (data not shown) were also observed.  Unlike that of the TNF-α 
response, IL-8 protein levels (Fig. 4.4) continue to increase overtime out to 72 hr post-
challenge, regardless of nuclear NF-κB amount, however, the initial production of IL-8 is 
altogether abrogated when NF-κB translocation is blocked (Fig. 4.5).  Similarly, Mpiga 
et al. (2006) showed that IL-8 expression was sustained, while TNF-α levels peaked 
and decreased in cultures infected with Chlamydia trachomatis.  Control of IL-8 
expression has been shown to be regulated by several signaling pathways and 
transcriptional regulators, including, but not limited to NF-κB.  Additional pathways may 
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be required for the stabilization of IL-8 mRNA allowing for sustained levels of IL-8 
expression (Hoffmann et al., 2002).  Taken together, our studies illustrate a mechanism 
involving the nuclear translocation of NF-κB which initiates an immediate inflammatory 
response against the parasite, but requires a second mechanism to sustain levels of IL-
8.  This mechanism may be used to prevent an over reaction of the inflammatory 
response, but continues to produce a potent chemokine that will attract additional cells 
for pathogenic clearance.  
These studies show that TLR are involved in the recognition of Encephalitozoon 
spores, not only in classically transfected cell lines, but also in primary cells.  Studies 
using transfected HEK293 cells showed that TLR2 alone was sufficient to induce IL-8 
production, whereas TLR4 alone or TLR4 in collaboration with the accessory molecules 
MD2 and CD14 were not (Fig. 4.1).  Additionally, heat-inactivated E. cuniculi stimulated 
a TLR2 mediated response observed at levels lower than that observed with viable 
spores.  This may simply be attributed to the method of parasite inactivation which may 
cause molecular alterations to the spore coat that lessens the ability of TLR2 
recognition.  Similar differential cytokine responses were observed between viable and 
heat-inactivated Candida albiacans, and so it was suggested that increased 
temperature may manipulate structural moieties found on the yeast surface that 
influence receptor recognition and responses (Gantner et al., 2005; Netea et al., 
2006b).  Alternatively, it may indicate that the PAMP is located on a parasite surface 
which is only exposed during or after leaving the exospore.  This would predict that the 
spores would have to be viable to trigger TLR2 pathways.  
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Macrophages are professional antigen-presenting cells found at mucosal barriers 
and are equipped with TLR to recognize a variety of pathogens (Janeway et al., 2005). 
To provide evidence for the direct role of TLR in the recognition of Encephalitozoon 
spp., siRNA was utilized to knock down the expression of TLR2 in primary human 
macrophages.  Our results indicate that NF-κBp65 nuclear translocation is inhibited and 
TNF-α and IL-8 production is reduced by almost 50% in knockdown cultures stimulated 
with either species of microsporidia (Fig. 4.6).  In addition, a reduction in the 
chemokines CCL3 and CCL4 was also observed in these cultures.  Although we 
observed decreases in TNF-α, IL-8, CCL3, and CCL4, the production of these 
inflammatory mediators were not completely abrogated via our siRNA model, and thus, 
it remains possible that the pathogens can be recognized by additional receptors that 
have not been described in this study.   
Although no specific agonists from microsporidia spore coats or sporoplasms 
have been defined in TLR recognition, molecules from the exospore, endospore, polar 
filament and sporoplasm are rapidly being identified, some of which have a striking 
resemblance to molecules from other microorganisms that are TLR agonists.   Cell wall 
components of fungi, such as zymosan and β-glucan, have proven to be potent 
stimulants of inflammatory responses by signaling through TLR.  Recently, linear O-
linked mannosylated glycans derived from the spore coat were described in E. cunniculi 
(Taupin et al., 2007)  These microsporidia glycans closely resemble molecules found on 
the surface of C. albicans that trigger TLR activation (Netea et al., 2006b).  Additionally, 
proteins identified in the endospore are believed to be attached to the membrane by 
GPI-anchors.  GPI-anchors derived from Trypanasoma cruzi and Toxoplasma gondii 
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have been identified in stimulating TLR2 (Campos et al., 2001; Debierre-Grockiego et 
al., 2007).  This innate recognition has been portrayed as one way that our defenses 
can identify self from non-self, and begin an immediate response that will result in 
pathogenic clearance.  It has also been described as a mechanism of immune evasion 
for pathogens (Netea et al., 2005). 
Our data presented show that the opportunistic pathogens of the 
Encephalitozoon spp. induce TLR2 signaling, which leads to the immediate nuclear 
translocation of NF-κB and subsequent production and secretion of TNF-α and IL-8 
inflammatory mediators.  These studies have also raised further questions about 
additional unidentified receptors potentially involved in microsporidia recognition and/or 
signaling molecules involved in immunosuppression, which will be addressed in future 
studies.  Defining the host-parasite interaction at the molecular level is helpful in 
understanding the pathology of the disease and developing possible methods of 
treatment and prevention.   
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CHAPTER 5 
CONCLUSION 
Summary 
Microsporidians are a significant cause of disease in immunocompromised 
individuals, however, existing information regarding the immunobiology of the disease in 
humans is limited and not well understood (Didier and Bessinger, 1999; Khan et al., 
2001).  Encephalitozoon spp. of microsporidia are known to infect enterocytes and 
macrophages in humans and have been reported in disseminated infections (Didier et 
al., 2004; Khan et al., 2001; Orenstein, 2003).  Dissemination of the disease is believed 
to occur through the migration of infected macrophages, as suggested by pathology 
reports (Kolter and Orenstein, 1999; Orenstein, 2003).  The contributions of 
macrophages to either resolution of or progression of disease have been underreported 
and often conflicting when published.  The work included in this dissertation is focused 
on determining the role of primary human macrophages in response to parasite 
challenge with Encephalitozoon cuniculi and Encephalitozoon intestinalis in a well 
defined in vitro system. 
Kinetics of Encephalitozoon spp. Infection of Human Macrophages.  While 
in vivo pathogenesis reports clearly indicated macrophages were found in tissues with 
parasitophorous vacuoles containing spores (Kolter and Orenstein, 1999), previous in 
vitro modeling has produced conflicting evidence of microsporidia entry and intracellular 
fate (Couzinet et al., 2000; Franzen et al., 2005b; Weidner, 1975).  Using several 
different methods which label spore coat, sporoplasm, and replicating meronts, we 
established a well defined in vitro model that clearly delineates the kinetics of infection, 
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including parasite adherence, uptake, replication, and spore production in primary 
human macrophages. 
Classical entry mechanisms of microsporidia require the eversion of the polar 
filament and expulsion of the sporoplasm into the host cell; however, an alternative 
method of infection in macrophages has been described as an actin-dependent 
phagocytic process (Couzinet et al., 2000; Franzen et al., 2005b).  Supporting the 
alternative method of infection, our SEM observations indicated a lack of polar filament 
firing, but an intimate association of host membrane partially surrounding the spores.  
Using a novel spore coat dye, we identified that this strong microbial-host association 
was quickly developed as nearly half of MDM were tightly adorned with spores by 1 hr 
post-challenge.  In agreement with Franzen et al. (2005a), spores were rapidly 
internalized by macrophages and an observed 50% of MDM by 48 hr post-challenge 
contained peri-nuclear vacuoles of sporoplasms. 
Parasite manipulation of intracellular signaling pathways in macrophages leading 
to host cell susceptibility and microbial proliferation is a common phenomenon (Pieters, 
2001) that has been suggested to occur with microsporidia (Weidner, 1975).  More 
recent studies have focused on the intracellular fate of human virulent strains of 
microsporidia in macrophages and suggest that the parasite is susceptible to 
intracellular killing mechanisms that limit microbial proliferation (Couzinet et al., 2000; 
Franzen et al., 2005b).  Using the bromodeoxyuridine (BrdU) assay to monitor parasite 
replication in terminally differentiated monocyte-derived-macrophages (MDM), we 
observed definitive microsporidia replication that resulted in the production of mature 
spores and confirmed our hypothesis that macrophages are susceptible host cells for 
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microsporidia development.  Greater than 30% of MDM contained vacuoles of parasite 
that stained positive for BrdU by 72 hr post-challenge and increased at later times.  In 
agreement with Didier et al (1994), treatment of MDM with IFN-γ and LPS, two known 
inducers of classical macrophage activation, resulted in decreased parasite replication, 
which suggests a need for Th1 responses to induce parasite killing.  However, total 
parasite replication was not ablated; therefore, activated macrophages may contribute 
by limiting the disease, but may require additional responding effector cells to establish 
disease resistance. 
Induction of Host Chemotactic Response by Encephalitozoon spp.  Many 
host-pathogen interactions result in the production of chemokines which lead to the 
localization of effector cells to these sites in order to establish microbial clearance 
(Chensue, 2001).  Pathology reports have shown that enteric infections of microsporidia 
cause an increase in numbers of macrophages in the lamina propria, some of which 
were shown to contain spores (Kolter and Orenstein, 1999; Soule et al., 1997).  In 
disseminated cases of microsporidiosis, infiltrates of spore containing macrophages 
have been identified in lesions of affected organs (Shadduck and Orenstein, 1993; 
Yachnis et al., 1996), however extracellular parasites have not been reported in the 
blood or lymph.  These reports suggest that macrophages migrate to localized areas of 
infection to contribute to pathogenic clearance, but are instead, manipulated to act as a 
vehicle for the spread of the organism. 
While reports of disseminated disease suggest the potential involvement of 
chemokines, previous evidence for the production of and functional recruitment by these 
factors has not been investigated.  We describe here that microsporidia infected MDM 
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express a strong and diverse chemokine profile and show that these infections lead to 
the recruitment of monocytes.  Analysis of focused gene and protein arrays of infected 
MDM revealed increases in the expression of several chemokines involved in leukocyte 
trafficking.   A closer look at the temporal expression of three monocyte attracting 
chemokines, which were upregulated on the microarrays, showed peak levels of CCL2, 
CCL3, and CCL4 between 12-24 hr post-challenge and remained elevated out to 72 hr, 
which, based upon our infection kinetics, show that these data correlate to the 
merogony stages.  In chemotaxis assays, the neutralization of CCL2 and CCL3 
chemokines resulted in a significant decrease of monocyte recruitment, whereas the 
greatest decrease was observed with the neutralization of CCL4.  These data suggest 
that the recruitment of monocytes to infected sites is partially induced by the production 
of CCL2, CCL3, and CCL4 and results in the recruitment of microsporidia susceptible 
host cells that have the potential for dissemination. 
TLR2 Recognition of the Microsporidia Encephalitozoon spp. Induces 
Nuclear Translocation of NF-κB and Subsequent Inflammatory Responses.  
Pattern recognition receptors (PRR) have been identified in the recognition of a number 
of pathogenic organisms; however, no molecules have been found which recognize 
microsporidia and stimulate an immune response.  In macrophages, the immediate 
initial inflammatory responses can be generated by microbial interactions with germline 
encoded PRR that are able to identify particular structural and chemical moieties found 
on the organism (Medzhitov, 2007).  The toll-like receptors (TLR), one family of PRR, 
have been shown to recognize molecules found on a number of parasites and fungal 
organisms that are similar in chemical structure to those identified on microsporidia 
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(Debierre-Grockiego et al., 2007; Netea et al., 2006; Peuvel-Fanget et al., 2006; Xu et 
al., 2006).  Additionally, TLR are known to regulate chemokine expression via NF-κB 
pathways (Grove and Plumb, 1993; Kunsch and Rosen, 1993).  These data suggest 
that TLR may contribute to microsporidia recognition and subsequent immune 
responses. 
In this study, we show that both E. cuniculi and E. intestinalis are recognized by 
TLR2 and that this interaction triggers inflammatory responses in macrophages.  We 
observed that microsporidia-challenged MDM resulted in the nuclear translocation of 
NF-κB and the production of TNF-α and IL-8.  The direct role of TLR2 parasite 
recognition in the activation of NF-κB and the production of cytokines and chemokines 
was confirmed by siRNA knockdown of TLR2 expression levels in primary human 
macrophages.  This knockdown resulted in decreased nuclear amounts of NF-κB and 
lower levels of TNF-α, IL-8, CCL3, and CCL4.  Taken together, these experiments 
suggest that TLR2 is a key molecule in the activation of initial inflammatory responses in 
primary human macrophages after challenge with Encephalitozoon spp. and may be 
partially responsible for the recruitment of monocytes/macrophages to infected tissues.  
Potentially, the development of host-tolerant molecules that target and disrupt TLR2-
Encephalitozoon interactions may lead to the discovery of more effective 
chemotherapeutics that contribute to the prevention of disseminated disease.  
In conclusion, the work described in this dissertation has provided a greater 
understanding for the host-parasite interactions between macrophages and 
microsporidia of the Encephalitozoon spp. and the subsequent innate immune 
responses.  These studies have better defined an in vitro model to look at 
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Encephalitozoon spp. infections of primary human macrophages.  Our investigations 
have confirmed the supporting role of macrophages in parasite proliferation and 
established the potential for their part in initiating extraintestinal dissemination.   These 
studies are the first to describe a host receptor family involved in the recognition of 
microsporidia.  Specifically, these data show that TLR2 recognizes Encephalitozoon 
spp. and generates inflammatory responses, which consist of known chemokines 
needed to recruit additional monocytes for potential proliferation and spread of 
microsporidia. 
Future Research Goals 
Reports of disseminated cases of microsporidiosis and the lack of information 
regarding macrophages potential role in parasitic spread make this research a very 
interesting and important area of further investigation.  The prevalence of microsporidia 
in immunocompromised individuals and healthy people, together with the fact that 
effective treatment has yet to be discovered, pose a very real threat of continued multi-
organ infections and fatality.  By elucidating receptors and subsequent signaling 
pathways involved in microsporidiosis, these understandings may help to develop 
potential treatments against the newly recognized targets. 
While our studies address the production of a functional chemokine gradient and 
recruitment of monocytes in response to infection, direct evidence for the role of 
macrophages in microsporidia dissemination to extraintestinal sites has not been 
shown.  One method to investigate macrophages potential would require the use of a 
murine system, in which the macrophage population has been depleted.  After inducing 
intestinal infection, animals could be monitored for the development of disseminated 
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multi-organ infections.  The role of individual chemokines in dissemination could be 
addressed by challenging chemokine knock out mice with parasite and monitoring for 
the development of infection in organs.  To establish a direct link between chemokines 
and macrophage dissemination, the adoptive transfer of individual chemokine receptor 
knock out macrophages into a murine model depleted of macrophages and analysis of 
disease development could be completed.  Additionally, our data suggests that TLR2 
activates chemokine responses.  TLR2 knock out macrophages may be transferred into 
a previously described macrophage depleted murine model to assess the receptors role 
in parasite dissemination. 
TLR are know to recognize a number of molecular moieties found on pathogens, 
and have more recently been shown to activate responses in concert with additional 
PRR (Mukhopadhyay et al., 2004; Takeda and Akira, 2005).  Our data clearly shows a 
decrease in inflammatory immune responses when TLR2 is knocked down in MDM; 
however, cytokine levels produced by knock down cells are still elevated above 
controls.  This suggests that microsporidia may be recognized by additional PRR to 
stimulate a full immune response.  The collaboration of TLR2 with other PRR in 
microsporidia infections could be examined by constructing additional siRNA that target 
PRR of interest.  Both, TLR2 and target PRR siRNA, could be transfected into MDM 
and infected cultures would be analyzed for cytokine levels.  Understanding host 
receptor involvement in microsporidia infections would contribute to our knowledge of 
host-pathogen interactions and significantly progress microsporidia research. 
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